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Executive Summary 
A meeting was convened on February 22-24, 2005 in Charleston, South Carolina to bring 
together researchers collaborating on the Bottlenose Dolphin Health and Risk Assessment 
(HERA) Project to review and discuss preliminary health-related findings from captured 
dolphins during 2003 and 2004 in the Indian River Lagoon (IRL), FL and Charleston 
(CHS), SC. Over 30 researchers with diverse research expertise representing government, 
academic and marine institutions participated in the 2 Y, day meeting. 
The Bottlenose Dolphin HERA Project is a comprehensive, integrated, multi-disciplinary 
research program designed to assess environmental and anthropogenic stressors, as well 
as the health and long-term viability of Atlantic bottlenose dolphins (Tursiops truncatus). 
Standardized and comprehensive protocols are being used to evaluate dolphin health in 
the coastal ecosystems in the IRL and CHS. The Bottlenose Dolphin Health and Risk 
Assessment (HERA) Project was initiated in 2003 by Dr. Patricia Fair at the National 
Oceanic and Atmospheric Administration/National Ocean Service/Center for Coastal 
Environmental Health and Biomolecular Research and Dr. Gregory Bossart at the Harbor 
Branch Oceanographic Institution under NMFS Scientific Research Permit No. 998-
1678-00 issued to Dr. Bossart. Towards this end, this study focuses on developing tools 
and techniques to better identifY health threats to these dolphins, and to develop links to 
possible environmental stressors. Thus, the primary objective of the Dolphin HERA 
Project is to measure the overall health and as well as the potential health hazards for 
dolphin populations in the two sites by performing screening-level risk assessments using 
standardized methods. The screening-level assessment involves capture, sampling and 
release activities during which physical examinations are performed on dolphins and a 
suite of nonlethal morphologic and clinicopathologic parameters, to be used to develop 
indices of dolphin health, are collected. Thus far, standardized health assessments have 
been performed on 155 dolphins during capture-release studies conducted in Years 2003 
and 2004 at the two sites. A major collaboration has been established involving 
numerous individuals and institutions, which provide the project with a broad assessment 
capability toward accomplishing the goals and objectives of this project. 
The objectives of the meeting were to: 
• review findings to date on the health assessment of IRL and CHS dolphins 
• identifY meaningful health indices and their implications 
• identifY existing data gaps and advise on future directions 
Researchers provided an overview of their subject matter, described those analyses which 
have been completed, provided a summary of their findings to date, indicated what other 
potential data might be useful in interpreting and understanding their findings, described 
the health implications of these correlations, and identified any planned publications. 
Abstracts of all presentations are included in this report. Breakout groups convened into 
working groups (I. Pathology/Epidemiology, II. Immunology, III. Molecular, Cellular 
and Contaminants, IV. Microbiology/Nutrition) on the afternoon of February 23 to 
discuss finding among the studies and which parameters may be important and sensitive 
indicators for assessing dolphin health. Discussion topics also addressed what other 
measurements and research approaches might be considered. Discussion leaders reported 
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summaries from each of the research areas the during the morning session on February 
24. A consensus from the group discussions highlighted the need to integrate and 
standardize data and discussion centered on ways in which this could be done. In order 
to conduct assessment on a complex and large data set it was proposed that a tiered 
approach be developed. The first tier would develop criteria for determining "healthy" 
animals identified by veterinary observations and body condition (Tier I) and the health 
status would be further delineated using CBC/serum chemistries (Tier II) followed by 
other health related data (Tier III). A Data Integration/Standardization Committee was 
proposed to facilitate data comparisons in all areas both categorically and statistically in a 
consistent manner among data sets. 
Thus far, preliminary findings indicate several differences between dolphins who inhabit 
the IRL and those that reside along the Charleston coastal regions. Some of these 
findings reported at the Researcher Meeting are highlighted below: 
~Indian River Lagoon dolphins show higher signs of infectious diseases, such as 
lobomycosis, which was found to occur only in the south IRL at a 30% prevalence. 
Benign mucocutaneous neoplasia associated with novel papilloma and herpes viruses 
have been documented in IRL study dolphins (see Reif et al., ABSTRACT). 
~Cytological evaluations in 2003 indicate higher occurrence of severe acute gastric 
inflammations in the IRL dolphins compared to the CHS dolphins, but lower levels for 
both populations occurred during 2004. 
~Immunologic evaluations indicate difference in immune responses with the IRL 
dolphins having higher innate responses evidenced by higher plasma lysozyme and 
monocte phagocytosis than animals in Charleston. In contrast, animals in IRL exhibited 
lower B-cell proliferation than animals in Charleston (see Peden-Adams and Romano 
ABSTRACT; Romano et al., ABSTRACT). 
~Results to date indicate that the Charleston dolphins have a higher body burden of 
persistent chemicals. Measurements include perfluorinated compounds that have 
emerged as priority contaminants due to recent reports regarding their persistence in 
environmental and biological samples as well as concerns regarding their 
toxicity. Results to date suggest that the Charleston animals have the highest average 
perfluoroctane sulfonate in plasma of any dolphin population studied (see Magali et al., 
ABSTRACT) and among the highest of any species (marine and freshwater) surveyed to 
date. And these results are consistent with the biomarker studies examining cytochrome 
P4501A1 expression (see Montie et al., ABSTRACT). 
~Antibiotic resistance of Esherichia coli bacteria in fecal samples was evaluated for 
resistance to 25 antibiotics during the health assessment studies. Results from 2003 
indicated that of the 15 animals captured in the IRL, three (20%) exhibited antibiotic 
resistance to one or more of the antibiotics tested. Of the 23 animals captured in CHS 16 
(70%) exhibited resistance to one or more of the antibiotics tested (see Bemiss et al., 
ABSTRACT). Data from this study on antibiotic resistant E. coli in wild caught dolphins 
will be included in a larger assessment of health and environmental parameters to further 
our understanding on the transfer and potential impacts of antibiotic resistance in coastal 
dolphins. 
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Early findings from the comprehensive health assessments of dolphins in the IRL and 
Charleston are revealing differences in several health parameters between these animals, 
and several new tests and tools have promising applications. Conducting health 
assessment studies over the 5-year timeframe is critical to identifying trends and 
addressing variability between years. Comparisons between two distinct populations 
over time will help researchers identify factors that pose the greatest health risks to these 
dolphins and determine their relationships to environmental exposures. 
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Overview of the Bottlenose Dolphin Health & Risk Assessment Project 
Patricia A. Fair1 and Gregory D. Bossart2 
1National Oceanic and Atmospheric Administration/National Ocean Service/Center for 
Coastal Environmental Health and Biomolecular Research, Charleston, SC; 2Harbor 
Branch Oceanographic Institution, Ft. Pierce, FL 
A multi-disciplinary study initiated in 2003 evaluated the health of bottlenose dolphin 
(Tursiops truncatus) populations at two U.S. sites in the southeastern United States: 
Charleston, South Carolina (CHS) and the Indian River Lagoon, Florida (IRL) (Figs 1, 2, 
and 3). A specific goal was to assess anthropogenic and environmental factors that might 
affect dolphin health. During the summer seasons of Years 2003 and 2004 (June in the 
IRL and August in CHS) 155 bottlenose dolphins were captured, examined, sampled, 
marked and safely released. This study focuses on developing tools and techniques to 
better assess health of bottlenose dolphins, as well as to identifY health threats and 
develop links to possible environmental stressors. Additional research goals were to: 1) 
evaluate dolphin health from individual, population and comparative perspectives at two 
distinct geographic locations, 2) apply classical and novel methods and diagnostic tools 
to detect and assess anthropogenic and environmental factors that affect dolphins, and 3) 
use these data to develop predictive models which evaluate conservation and 
management strategies. These comprehensive investigations are aimed at understanding 
the cumulative effects of multiple stressors and will ultimately provide information 
critical to the preparation of effective management plans. One ofNOS/CCEHBR goals, 
consistent with NMFS mandates, is to validate and optimize a comprehensive suite of 
meaningful parameters that can be applied to evaluate health of dolphin populations 
throughout their geographic range. 
The HERA Dolphin Project was design~d as a 5-year project as outlined below. 
HERA Dolphin Project 5-Year Timeline 
Population-level Exploration of 
1
site characterization I J Stressor Indentifcation & risk analysis J I characterization II management strategi~ 
I Development of marine mammal population risk I 
Research & development of diagnostic tools 
I 
I Apmm' Uve.capture of dolphins fnr measurement of health judjcatorskontami~ant loads I 
Monitoring of dolphins in IRL & CHS through photo-ID, stranding response 
f I I I I 
Ft 
I I I I 
FY FY FY FY 
03 04 OS 06 07 
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Site Investigations 
The health assessment of dolphins is especially critical in areas where stocks are depleted 
or show signs of epidemic disease or high mortality, and in areas where the habitat is 
being intensely altered or impacted by human influences. Recent studies, as well as 
observations and expert recommendations, highlight the need for a bottlenose dolphin 
health assessment at the IRL and CHS sites. The National Coastal Condition Report 
(2001 , 2004) described ecological conditions in southeastern estuaries as "fair" , with a 
high level of contaminants detected over moderate areas and low-level contamination 
over broader areas, particularly pesticides and metals. Of the Carolinian province, nearly 
772 from a total of 4,487 square miles were ecologically degraded in respect to benthos. 
The bottlenose dolphin represents a key component in both the Indian River Lagoon and 
Charleston ecosystems. Further, as an apex predator, bottlenose dolphins serve as a 
sentinel species for monitoring the health of the environment. 
Indian River Lagoon, Florida (IRL) : The IRL is a shallow water ecosystem that 
comprises 40% of Florida's central east coast. Human population growth adjacent to the 
Indian River Lagoon increased from 1970-1990 by 124% and is projected to reach 1.1M 
by 2010 (Indian River Lagoon National Estuary Program 1990). The IRL extends 250 
km from Ponce De Leon Inlet in the north to Jupiter Inlet in the south and consists of 
three estuarine bodies of water, the Indian River, Banana River and Mosquito Lagoon. 
For the health assessment capture-release studies, the IRL was divided into two separate 
areas consisting of a north and south site. Dolphins captured in the IRL during 2003-
2004 are shown in Fig. 1 and 2. The IRL is connected to the Atlantic Ocean by six small 
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(1-"-
, 
I I 
80 18·o·w 80 1zo·w 80 s·o·w 
Figure 2. Indian River Lagoon (south site) 2003 
and 2004 captured dolphins. 
and widely spaced inlets. Exchange of waters between the Lagoon and ocean is limited 
due to the size of these inlets and the shallow nature of the Lagoon. As a consequence of 
limited circulation and tidal exchange, the lagoon is particularly vulnerable to the influx 
of pollutants. Water quality in the IRL has changed significantly over the past five 
decades due to significant watershed alteration and land drainage patterns. The major 
cause of water quality decline is fresh and storm water discharges that alter salinity, water 
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clarity and introduce nutrients and pollutants into the system (Scott eta!. 2003). All of 
Florida's sugarcane, approximately 38 %of the citrus and 42% of the vegetable crops are 
grown in an area that drains into the IRL (Miles and Pfeuffer 1997). 
Presently, there is concern for the overall health of the IRL ecosystem due to destruction 
of sea grass habitat, alteration of water flow, and declining water quality. Examination of 
benthic distributions in the southeast U.S. showed that large tidal rivers such as the IRL 
had the largest proportion of their estuarine bottom area represented by poorer than 
expected benthic estuaries and that significant sediment toxicity associated with sediment 
existed at Newfound Harbor in the IRL (National Coastal Condition Report, 2001 ). 
Recent data collected by NCCOS/CCMA scientists and others have shown high levels of 
copper, as well as mercury, in the sediments of the St. Lucie Estuary in the southern part 
of the IRL. In addition, these same data have shown increasing levels of copper 
concentration in Indian River Lagoon bivalves. 
Dolphins in the IRL have experienced high rates of seasonal strandings since 1996 
(Stolen 1998). In 2001, an unusual mortality event of unknown etiology occurred in the 
northern portion of the IRL, in which at least 30 dolphins died over a two month period 
(MMC 2002). A substantial proportion of the observed mortality in the IRL is due to 
infectious diseases, and many have been diagnosed with a variety of skin lesions, 
including proliferative ulcerative dermatitis due to protozoans and fungi, dolphin pox 
dermatopathy, and a vesicular dermatopathy of unknown etiology (Bossart eta!. 2003). 
Understanding the pathologic features associated with mortality of stranded dolphins is 
important, and observed patterns of skin, lymphoid and other lesions suggested a state of 
altered immunologic homeostasis and subsequent immunologic dysfunction. 
Charleston, South Carolina: Charleston Harbor is a 1,939km2 estuarine environment 
formed by three river systems, the Cooper, the Ashley, and the Wando. It is located in 
the central portion of South Carolina and the river systems form the third largest estuarine 
drainage area in South Carolina, over 26,000 ha of valuable marshland and tidal habitat 
(Tiner, 1997). The Charleston Harbor estuary has a soft mud bottom. Average depth is 12 
mat low tide and it varies in width from 120 to 300m. The Charleston-Harbor-Cooper 
River coastal plain measures 66 km2 with an additional 105 km2 of intertidal wetlands. 
The estuary is subject to semidiumal tides with a mean range of 1.6 m near the ocean. 
Long-term trends in water quality monitoring and recent scientific research suggest that 
waste load assimilation, nonpoint source runoff impacts, contaminated sediments, and 
toxic pollutants are key issues. In addition, several 'hot spots' showing high levels of 
heavy metals and organic compounds have been identified with high levels of heavy 
metals and organic compounds have been identified. High concentrations of 
anthropogenic trace metals, polychlorinated biphenyls (PCBs) and pesticides have been 
found in the sediments of Charleston Harbor, as well as the Ashley and Cooper Rivers 
(Long eta!. 1998). Two superfund sites are found in the Charleston Harbor area and its 
tributaries, with the following key contaminants of concern: petroleum aromatic 
hydrocarbons (P AH), lead, chromium, copper arsenic, zinc and dioxin. The Charleston 
Harbor estuary is surrounded by urban development and has the second largest container 
port on the Atlantic seaboard and is the fifth largest U.S port. Additionally, two sewage 
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treatment plants also discharge into the basin. Among the three rivers, the Cooper River 
has the greatest number and density of industrial and port facilities and over 95% of the 
total pollutant loads are thought to be from point sources. Population from 1970-1990 
grew 66% in the Charleston tri-county area with slightly over 500,000 people currently. 
It is the fastest growing metropolitan South Carolina area and another 600,000 people are 
projected by 2015 (U.S. Census Bureau, 2000). 
In addition to the Charleston Harbor estuarine areas, the study area for the dolphin health 
assessment study extends to an adjacent area, the Stono River Estuary, approximately 20 
km southwest of Charleston Harbor. This area is characterized as a well-mixed, C-type 
salt marsh estuary, with little freshwater inflow (Day et al. 1989), small tidal inlets with 
extensive mud banks and marsh vegetation, and is influenced primarily by residential 
development. Dolphins captured in the Charleston Harbor and Stono River estuarine 
areas during 2003-2004 are shown in Fig. 3. 
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Figure 3. Charleston Harbor and Stono River estuary 
2003 and 2004 captured dolphins. 
Dolphins inhabiting the Charleston habitat do not show evidence of the skin lesions 
found in IRL dolphins. However, an increase in commercial development and the 
proximity of heavy industrial and agricultural influences in the CHS area suggests a 
potential for detrimental effects on dolphin health. Biopsy samples taken from dolphins 
in CHS during the last five years reveal higher concentrations of persistent organic 
contaminants in blubber compared to IRL dolphins, which, in turn, may indicate a greater 
level of environmental contamination from these compounds. 
In order to enhance the validity of comparisons between the two study populations, 
uniform collection and sampling processing methods used standardized operating 
protocols (SOPs) with Quality Assurance /Quality Control measures for the capture-
release studies, animal handling and sample collection. Included among these 
comprehensive and standardized health assessment protocols were a complete physical 
examination, ultrasound examination, measurement of morphometric variables and 
weight, collection of blood, urine, and various tissues for hematology, serum chemistry, 
microbiology, immune function, and an extensive suite of biomarkers. A comprehensive 
array of tests and measures was developed for the Dolphin HERA Project and includes 
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over 170 physical, clinical and chemical tests/analyses/measurements, in addition to more 
than 250 traditional and emerging contaminants. Early in 2004 the Dolphin HERA 
Project developed Safety Standard Operating Protocols for the conduct of dolphin 
capture-release studies. 
Assessment of dolphin health with envirorunental parameters is a key component of the 
HERA Project. Envirorunental characterization efforts are on-going at both sites using 
current and historical monitoring data. The health assessment component is using an 
integrated approach by identifying stressors (physical, chemical, envirorunental) and 
linking diagnostic observations across levels of biological organization (toxicant, macro-
molecular interactions, cellular responses, organ responses, individual and population 
responses). A proposed concept was to link envirorunental data, such as those utilized in 
the National Coastal Condition report, with the HERA dolphin health data as an 
integrated assessment. Long-term dolphin photo-identification studies at both sites will 
provide baseline data to compare health parameters of dolphins having known site 
fidelity and potential envirorunental exposures. 
During 2004, 39 dolphins were captured in the IRL and 24 in CHS bringing the total 
nrunber of captured animals for the HERA Project to 155 for the first two years. Thus 
far, preliminary fmdings indicate several differences between dolphins who inhabit the 
IRL and those that reside along the Charleston coastal regions. Indian River Lagoon 
dolphins show higher signs of infectious diseases, such as lobomycosis, which was found 
to occur only in the south IRL at a 30 % prevalence. Benign mucocutaneous neoplasia 
associated with novel papilloma and herpes viruses have been docrunented in IRL study 
dolphins. Cytological evaluations in 2003 indicate higher occurrence of severe acute 
gastric inflammations in the IRL dolphins compared to the CHS dolphins, but lower 
levels for both populations occurred during 2004. Immunologic evaluations indicate 
difference in iminune responses with the IRL dolphins having higher innate responses 
evidenced by higher plasma lysozyme and monocte phagocytosis than animals in 
Charleston. In contrast, animals in IRL exhibited lower B-cell proliferation than animals 
in Charleston. Results to date indicate that the Charleston dolphins have a higher body 
burden of persistent chemicals. We have expanded our measurements to include 
perfluorinated compounds which have emerged as priority contaminants due to recent 
reports regarding their persistence in envirorunental and biological samples as well as 
concerns regarding their toxicity. Results to date suggest that the Charleston animals have 
the highest average perfluoroctane sulfonate in plasma of any dolphin population studied 
(see Magali eta!., ABSTRACT) and among the highest of any species (marine and 
freshwater) surveyed to date. And these results are consistent with the biomarker studies 
examining cytochrome P4501Al expression. Antibiotic resistance of Esherichia coli 
bacteria in fecal samples was evaluated for resistance to 25 antibiotics during the health 
assessment studies. Results from 2003 indicated that of the 15 animals captured in the 
IRL, three (20%) exhibited antibiotic resistance to one or more of the antibiotics tested. 
Of the 23 animals captured in CHS 16 (70%) exhibited resistance to one or more of the 
antibiotics tested (see Bemiss eta!., ABSTRACT). Data from this study on antibiotic 
resistant E. coli in wild caught dolphins will be included in a larger assessment of health 
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and environmental parameters to further our understanding on the transfer and potential 
impacts of antibiotic resistance in coastal dolphins. 
Early findings from the comprehensive health assessments of dolphins in the IRL and 
Charleston are revealing differences in several health parameters between these animals, 
and several new tests and tools have promising applications. Conducting health 
assessment studies over the 5-year timeframe is critical to identifying trends and 
addressing variability between years. Comparisons between two distinct populations 
over time will help researchers identify factors that pose the greatest health risks to these 
dolphins and determine their relationships to environmental exposures. 
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The Bottlenose Dolphin HERA Database 
Jeffrey D. Adams 
NOAA, National Ocean Service, Center for Coastal Environmental Health and 
Biomolecular Research, Charleston, SC 
A substantial amount of data from many collaborators has been generated during the first 
two years of the Dolphin Health and Risk Assessment (HERA) project. The HERA 
database serves as the repository for these data. The database currently contains 3 7 data 
tables (Appendix A), the majority of which are linked using the freezebrand number 
assigned to each captured individual. These data tables contain approximately 7 50 fields, 
the contents of which are described in Appendix B. In addition to the data tables, the 
database also contains 56 lookup tables (Appendix C). Lookup tables are database 
conventions used to reduce storage requirements, minimize data entry errors, and speed 
up data processing routines. 
In addition to linking the data tables within the HERA database, the freezebrand number 
of the captured individuals also serves as a link to the Charleston, SC (CHS) and Indian 
River Lagoon (IRL) photo-identification databases. The link to the photo-identification 
databases is of particular importance as one of the primary research goals of the HERA 
Project is to examine the relationship between the measured dolphin health parameters 
and the health of the environment. To explore this relationship, it is necessary to examine 
the sighting histories of the captured individuals to determine the areas they traverse when 
conducting activities such as feeding, mating, and caring for young. While the capture of 
an individual may constitute the first known sighting for the individual, many of the 
captured individuals have sighting histories stored in the photo-identification database 
prior to capture. In addition, many have been sighted during photo-identification surveys 
subsequent to capture. These sighting histories will play a vital role in linking the health 
data back to the environment. Tools are currently being developed to assist researchers 
with little to no background in geographic information systems (GIS) or relational 
databases in displaying and analyzing the data contained in the health and photo-
identification databases within a GIS environment. 
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2003-2004 Live Captures: Demographics and Life History Information 
Wayne McFee, NOAA, NOS, Center for Coastal Environmental Health and 
Biomolecular Research, Charleston, SC 
General information on bottlenose dolphin demographics and life history was presented 
at the HERA live capture workshop on February 22,2005 in Charleston, South Carolina. 
This information is essential for the interpretation of many of the analyses that are being 
performed on these wild caught dolphins in the Indian River Lagoon (IRL ), Florida and 
Charleston, South Carolina. Data on age, length, weight, Body Mass Index (BMI), and 
girths were presented. Stained thin sections of 111 (51 Charleston; 60 IRL) teeth were 
aged following the methods ofHohn et al. (1989). Of these, 74 (33 Charleston; 41 IRL) 
were male and 37 (18 Charleston; 19 IRL) were female. The mean age ofma1es (CHS-
15.4, range 3.5- 28; IRL- 12.9, range 4.5-27) was greater than females (CHS- 12.6, 
range 3.5-33; IRL 9.7, range 3.5-26) at both sites with overall mean ages greater in 
Charleston than in the IRL. Asymptotic lengths were estimated using the Gompertz 
Growth Curve. Both sites exhibited sexual dimorphism with males reaching asymptotes 
at a greater length (CHS- 267.4 em, r2= .71; IRL- 276.3 em, 1= .79) than females (CHS 
-247.0 em, r2= .94; IRL- 251.0 em, 1= .83). These asymptotes probably do not reflect 
the actual asymptotic lengths of either population as the data is severely lacking 
information on animals < 5 and > 20 years of age. The use of ages from stranded 
dolphins would provide a more accurate representation of asymptotic lengths. For 
instance, when the Gompertz growth curve was used on South Carolina stranded animals 
and live capture animals the asymptotic lengths changed considerably, especially for 
males (male- 248.5 em, r2= .92; female- 240.5 em, 1= .93). During the process of 
viewing the growth layers in the teeth, pulp stones were observed from a number of teeth. 
These globular masses of secondary dentine were more prevalent in dolphins from the 
IRL (36.7%) than from Charleston (19.6%). Pulp stones were more common between the · 
growth layer groups (GLG's) 2-6 than at any other stage. Further investigation is needed 
on pulp stones to determine if they are indicative of health. 
Dolphins were stratified into one of five age-length classes: !)juvenile males (<15 
GLG's, <240 em), 2) juvenile females (<7 GLG's, <220 em), 3) adult males (2::15 GLG's, 
2::240 em), 4) adult females (2::7 GLG's, 2::220 em), and 5) pregnant females. Adult males 
were categorized based on testosterone levels of -3 ng/ml and higher. Caution should be 
used here, since some males <15 GLG's and <240 em could be considered adults. 
However, testosterone generally increased at these ages and lengths. Interestingly, mean 
testosterone levels reached a peak at approximately 20 years of age (16.7 ng/ml) and then 
decreased thereafter to 8.9 ng/ml. Charleston dolphins were heavily skewed toward adult 
males and the IRL was heavily skewed toward juvenile males. 
Weights were collected for 104 animals (IRL- 59; CHS -45). In both the juvenile and 
adult male categories, IRL animals were longer Guvenile M mean=222.5 em; adult M 
mean- 255.4 em) than their Charleston counterpart Guvenile mean- 209.8 em; adult 
mean- 252.5 em), but adult males in Charleston were heavier (CHS mean -422.llbs.; 
IRL mean- 395.5 lbs.). Females, although longer and heavier in the IRL as juveniles 
(IRL mean length- 203.4 em, IRL mean weight- 215.5 lbs.; CHS mean length- 193.0 
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em, CHS mean weight- 203.0 lbs.), were longer and heavier as adults in Charleston 
(CHS mean length- 242.3 em, CHS mean weight- 347.0 lbs.; IRL mean length- 235.8 
em, IRL mean weight- 314.6lbs.). 
Body Mass Index (BMI) was calculated (weight/length2) for 104 dolphins. Mean range 
BMI scores for Charleston were 24.4 Guvenile females) to 30.2 (adult males) and for the 
IRL were 22.5 Guvenile females) to 27.5 (pregnant females). With the exception of 
pregnant females, Charleston dolphins had higher mean BMI scores in each age category. 
The largest differences between the two sights were in the juvenile female (CHS- 24.4, 
s.d. - 3.0; IRL- 22.5, s.d.- 2.2) and adult male (CHS- 30.2, s.d.- 2.1; IRL- 26.8, s.d. 
- 4.0) classes. These differences in weight, length, and BMI between Charleston and IRL 
dolphins may simply be the occurrence of dolphins at a higher latitude in Charleston. 
When comparing northern IRL dolphins with southern IRL dolphins, the largest 
differences in BMI were between pregnant females (North- 23.0, s.d. -0; South- 29.0, 
s.d.- 2.6) and adult males (North- 25.5, s.d.- 4.2; South- 29.5, s.d.- 1.7). However, 
the pregnancy status of the one dolphin from the northern IRL is questionable, and 
therefore, this may not accurately reflect any differences in this age class. 
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Lobomycosis in Atlantic Bottlenose Dolphins (Tursiops truncatus) from the Indian River 
Lagoon, Florida. 
John Reif,l-2 M.S. Mazzoil,1 S.D. McCulloch1, R. A. Varela1, P. A. Fair, and G. D. 
Bossart1 
1Division of Marine Mammal Research and Conservation, Harbor Branch Oceanographic 
Institution, Ft. Pierce, Florida, USA; 2Department of Environmental and Radiological 
Health Sciences, Colorado State University, Fort Collins, Colorado, USA; 3National 
Oceanic and Atmospheric Administration, NOS Center for Coastal Environmental Health 
and Biomolecular Research, Charleston, South Carolina, USA. 
Lobomycosis is a mycotic infection of humans and dolphins caused by a yeast-like 
organism (Lacazia loboi). During a health assessment of bottlenose dolphins (Tursiops 
truncatus) from the Indian River Lagoon (IRL) along Florida's central east coast in 2003-
2004, 9 of75 (12.0%) dolphins sampled had histologically confirmed evidence of 
lobomycosis. In the southern section of the IRL, an area characterized by freshwater 
intrusion and lower salinity, the prevalence was 30.0 percent. Cases were not detected in 
the northern section oftbe 260 km waterway, nor among 71 dolphins sampled in 
estuarine waters near Charleston, SC. The reasons for the emergence of this rare 
infectious disease in the dolphin population of the IRL are unknown. Our findings 
suggest that exposure to environmental stressors may contribute to the unusually high 
prevalence of the disease. Alternatively, local environmental perturbations in salinity, 
temperature or vegetation may play a role in the expression of lobomycosis in this 
sentinel species. 
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Clinicopathologic Findings from the Health and Risk Assessment (HERA) Atlantic 
Bottlenose Dolphin Project: 2003-2004 
Gregory D. Bossart, R. Varela, J. Goldstein, D. Kilpatrick, and M. Rehtanz 
Division of Marine Mammal Research and Conservation, Harbor Branch Oceanographic 
Institution, Ft. Pierce, Florida USA 
In 2003 and 2004, a total of 155 Atlantic bottlenose dolphins (Tursiops truncatus) were 
collected, examined, sampled, marked and released in the Indian River Lagoon (IRL) FL 
(n=82) and Charleston (CHS), SC (n=73) under authorization ofNMFS Scientific Permit 
No. 998- 1678- 01. Following morphometric, body weight and ultrasonic blubber 
measurements, experienced marine mammal veterinarians performed complete hands-on 
physical examinations. Briefly, physical examination included visual and/or digital 
evaluation of the eyes, oral cavity, integument, genital slit, and nasal sacs with thoracic 
and abdominal auscultation and ultrasound exams (blubber, pleural, abdominal organs 
including reproductive tract). Blood (pre- examination and post-examination samples), 
cytologic specimens (gastric fluid, nasal sac and fecal), urine, a blubber biopsy and feces 
were taken via aseptic procedures for a wide range of diagnostic procedures previously 
outlined (Bossart 2003). Skin lesions were aseptically biopsied for later pathologic 
examination. A subjective body condition score was designed to indicate overall 
nutritional status. Along these same lines, an ultrasonic evaluation of postnuchal fat depth 
and echogenicity was designed in order to characterize this fat which may be more 
metabolically available than other previously measured fat stores. Goldstein et a!. and 
Varela eta!. review the blubber, hematologic and serum analyte data in this volume. 
Abnormal physical examination findings were uncommon except for mucocutaneous 
disease (see below). Abnormal exam findings included mild cachexia, grade 1-3 
pansystolic heart murmurs, mild to moderate unilateral corneal edema, mild to moderate 
gingival hyperplasia, and reduced range of motion of the pectoral fin with palpable callus 
formation, likely secondary to past skeletal trauma. 
Cytopathologic findings from gastric samples in the IRL in 2003 indicated a high number 
of animals with severe acute inflammatory changes (14% vs. 5% in CHS) (Fig. 1). In 
2004, IRL gastric samples with severe acute inflammation had a similar pattern as CHS 
( 4% vs. 6%, respectively). Blowhole and fecal samples from 2003 and 2004 from both 
sites had no pathologic findings. 
Skin lesions typical of recent and healed rake marks were common. Scarring patterns 
consistent with past shark attacks, as well as entanglement injury, were also common. 
Mucocutaneous infectious lesions included dolphin pox (Fig. 2), lobomycosis (Fig. 3), 
and newly documented oro genital sessile papillomas (Fig. 4). A novel papillomavirus was 
found in one genital papilloma using molecular methodology. A novel herpes-like virus 
was found in another sessile papilloma, which was demonstrated with transmission 
electron microscopy. Lobomycosis was found only in southern IRL dolphins and Reif 
reviews this disease in this volume. One 2004 dolphin with oral papillomas was 
previously captured in 2003, at which time the oral lesions were not present. 
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Figure 1- Gastric cytology from an IRL dolphin with abundant neutrophils consistent with severe acute 
inflammation. 
Figure 2 - Dolphin pox with characteristic microscopic inclusions (inset) . 
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Figure 3 - Lobomycosis with microscopic appearance (inset, arrow indicates multinucleate cell with 
cytoplasmic fungi). 
Figure 4 - Orogenital papillomas with herpes-like virus (inset, ultrastructural features with arrows 
indicating virions). 
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Clinicopathologic Findings from Atlantic Bottlenose Dolphins (Tursiops 
truncatus) Inhabiting the Indian River Lagoon, Florida 
Juli D. Goldstein1, E. Reese1, R. A. Varela1, R. H. Defran1, S.D. McCulloch2, J. S. Reif 2, 
P. A. Fair3, and G. D. Bossart1 
1 Harbor Branch Oceanographic Institution, Ft. Pierce, FL, 2Department of Environmental 
and Radiological Health Sciences, Colorado State University, Ft. Collins, CO; 3National 
Oceanic and Atmospheric Administration, NOS Center for Coastal Environmental Health 
and Biomolecular Research, Charleston, SC 
A joint five-year comprehensive research project was initiated in 2003 between Harbor 
Branch Oceanographic Institution in Ft. Pierce, Florida, and the National Ocean Service 
Center for Coastal Environmental Health and Biomolecular Research at Charleston, 
South Carolina (NMFS Permit No. 998-1678-01). The goal of this project is to study the 
health of Atlantic bottlenose dolphin (Tursiops truncatus) populations inhabiting the 
Indian River Lagoon (IRL ), Fl and the coastal waters of Charleston, SC. This 
presentation examined hematologic, serum biochemical, and cytologic variables in IRL 
dolphins in order to establish normal baseline values, which will be useful in subsequent 
health evaluations of these animals. 
Sixty-three samples were analyzed for serum biochemistry and 60 samples for 
hematology. Sixty-two gastric, fecal and blowhole specimens were also examined. The 
ages of dolphins examined ranged from 3.5 years - 26 years, and only apparently-
healthy dolphins were included in this study. Clinical health was based on veterinary 
physical exam evaluations. Animals exhibiting lesions such as lobomycosis or papillomas 
were automatically excluded. 
One-way ANOVAs were preformed on all hematological and biochemical values 
comparing males vs. females, pregnant vs. non-pregnant females, and juveniles vs. 
adults. There were no significant differences between males and females or between 
pregnant females and non-pregnant female hematologic values. Juvenile animals ( < 6 
years) had a higher mean MCH than adults (2::6 years), and adults had a higher relative 
percentage of segmented neutrophils. Differences in serum biochemistry were also 
found: females had a greater mean value than males for sodium, BUN, BUN/creatinine 
ratios, CPK, cholesterol, triglycerides, and iron. Non-pregnant females had a higher 
mean TIBC and albumin from serum protein electrophoresis than pregnant females. 
Juveniles had higher mean values than adults for BUN, BUN/creatinine ratios, CPK, 
triglycerides, iron, PSA T, and lipase. 
No significant pathologic findings were present in the fecal and blowhole cytologies for 
both years. However, 24% (7/29) of the dolphins examined in 2003 had evidence of 
gastric inflammation, and 13.8% (4/29) of those animals exhibited severe gastric 
inflammation. In 2004 only 4.2% (1/24) of the population exhibited mild or moderate 
gastric inflammation, no severe inflammation was present. 
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The Atlantic bottlenose dolphin represents an apex predator, yet is one of the least 
studied wildlife groups occurring within and along the IRL. No recent comprehensive 
health assessment of IRL bottlenose dolphins has been conducted for the IRL system, and 
it has been over 26 years since the last health study of IRL dolphins was completed. 1 
These findings and analyses represent the most complete hematologic, serum 
biochemistry and cytologic analyses reported to date for the IRL dolphin population and 
will provide a useful baseline for future studies on these animals, as well as other free-
ranging and captive populations. 
Table 1. Hematology baseline values for clinically healthy IRL bottlenose dolphins 
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Table 2. Serum Analyte baseline values for clinically healthy IRL bottlenose dolphins 
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Immune A G g/dl 0.44 1.74 1.04 0.21 63 
Lipemia 0 34 14.65 8.05 63 
Hemolysis 0 40 13.56 9.91 63 
Icterus 0 0 0 0 63 
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Evaluation of a Portable Clinical Analyzer for Assessment of Critical Care Blood Gases 
and Electrolytes in Atlantic Bottlenose Dolphins 
1Division of Marine Mammal Research and Conservation, Harbor Branch Oceanographic 
Institution, Ft. Pierce, FL; 2NOAA, Charleston, SC; 3NOAA/NOS/CCEHBR, Charleston, 
sc 
Atlantic bottlenose dolphins (Tursiops truncatus) are the most commonly stranded 
marine mammal on the southeast coast of the United States. It is also the most common 
marine mammal housed within oceanaria worldwide. Given both of these facts, the 
necessity to produce diagnostic tools for improving critical care and general health 
assessment of these animals takes on an added importance. In stranded bottlenose 
dolphins, a tool is necessary for rapidly assessing acid/base balance and electrolyte status, 
primarily to determine their long-term viability, and as with captive animals, to determine 
an appropriate treatment regime and response to current treatment. The i-Stat Critical 
Care Blood Gas Analyzer (Heska Corp., Fort Collins, CO) provides this potential 
functionality. In fact, this diagnostic tool has proven useful for determining metabolic 
health in other species. It has been shown to be precise, accurate, portable, rapid, and 
very field capable. With this in mind, this study had several objectives. Initially, our 
intent was to standardize i-STAT and its protocols for use in bottlenose dolphins. Once 
this was done, it was important to establish a normal range for wild dolphins and compare 
those values with those of a standard veterinary diagnostic laboratory. Finally, we 
intended to identifY changes in the iStat values associated with sample and animal 
processing times associated with the Dolphin HERA Project study. For this study, 154 
wild Atlantic bottlenose dolphins (Tursiops truncatus) (Charleston, SC and Indian River 
Lagoon, FL) and 15 Atlantic bottlenose dolphins in human care (Dolphin Discovery, 
Mexico) were utilized. Standard capture techniques as indicated in the HERA protocols 
and NMFS Permit# 998- 1678- 01 were utilized for the wild dolphins. Blood samples 
were taken from the periarteriolar venous rete (PA VR) of the flukes utilizing a 19ga, %" 
butterfly catheter and evacuated with a 1 m1 vented blood gas syringe with lyophilized 
lithium heparin. In the wild dolphins, blood samples were taken upon initial capture and 
after they were processed on the animal processing boat. Those animals in human care 
were sampled once in a voluntary, behaviorally conditioned session. Samples were 
processed as soon as possible by an iStat Critical Care Blood Gas Analyzer (Heska Corp., 
Fort Collins, CO), utilizing an EC8+ Cartridge. For the pre and post samples, the time 
period between the initial set of the net and the beginning of the blood draw was recorded 
and is referred to as the time-to-bleed (TTB) for that sample. The time between the 
completion ofthe blood draw and the run of the blood in the i-Stat was also recorded and 
is referred to as the time-to-run (TTR) for each sample. 
Effect of lag time in bleed and sample run on i-Stat results. A Generalized Linear Model 
was employed to investigate the effect of the continuous covariates, TTB and TTR, on 
each i-Stat parameter. In short, none of the parameters showed substantial deviation from 
model assumptions. Following the GLM analysis, adjusted values were calculated for 
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each parameter. For mean glucose and C02 values, samples were divided into three 
groups: time-to-run less than 10 minutes, time-to-run between 10 and 20 minutes, and 
time-to-run greater than 20 minutes, with the same treatment performed for time to bleed. 
It was found that the effect ofTTR (i.e., lag in run time) and TTB (i.e., pre vs. post) work 
in opposite directions, TTR is negatively correlated and TTB is positively correlated. 
Comparison ofi-Stat and laboratory measurements. Pearson's correlation coefficient was 
calculated to determine deviation from a best-fit line, which would indicate the precision 
of the measurements. Additionally, a Coefficient of Accuracy, Ca, was calculated to 
determine the deviation of the best fit line from the ideal45° line, which would indicate 
the accuracy of the measurements. Finally, the Concordance Correlation statistic was 
determined in order to provide a single statistic indicative of both accuracy and precision 
(Lin and Torbeck 1998). There was no good agreement on any of the parameters with the 
exception of BUN. Laboratory glucose values compared to i-Stat glucose values for a 
given individual showed a degree of scatter indicating low precision, but a relatively 
symmetric distribution around 45° line indicated good accuracy (i.e. no bias). Laboratory 
BUN value versus i-Stat BUN value for a given individual showed minimal scatter 
indicating good precision, but points distributed primarily above the 45° line indicated 
that i-Stat values tend to be slightly higher than laboratory values and lacked accuracy. 
Laboratory sodium, potassium, and chloride values versus i-Stat sodium, potassium, and 
chloride values for a given individual showed a lack of correlation indicating poor 
agreement, and i-Stat values tended to be lower as compared to laboratory values. 
In summary, the i-Stat critical care blood gas analyzer system was successfully used for 
field sampling in dolphins. Also, a normal range for several iStat analytes were 
established in wild dolphins (Table I), but more animals would need to be sampled to 
produce a dependable range for captive animals as well. Additionally, poor correlation 
existed between i-Stat and laboratory values, which preclude a lateral comparison of 
these values. However, there does appear to be good precision within the i-Stat, allowing 
for its independent use. Finally, significant differences were seen with increasing TTR 
and TTB, which can result in large degrees of sampling-induced error. It will be critical 
in future studies to limit the time to run a sample to less than 20 min. Likewise, reducing 
the time to the initial bleed during the HERA project is likely to result in fewer 
aberrations in the post bleeding indices. 
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Table 1: Wild Tursiops truncatus serum chemistry, hematology, and blood i-STAT 
values 
SERUM BLOOD iSTAT 
(n=154) Pre Post Pre Post (n=144) (n=114) (n=142) (n=112) 
Glucose (mgldL) 94.06 98.95 126.13 
+/-13.55 +/-14.93 +!- 22.01 
Blood Urea Nitrogen 62.76 66.39 66.99 
(mg/dL) +!- 9.20 +/-10.96 +/-11.19 
Sodium (mmol/L) 155.37 151.56 +/- 151.70 +/-
+!- 3.44 3.91 4.17 
Potassium (mmol/L) 3.89 3.84 3.61 
+!- 0.37 +!- 0.53 +/- 0.31 
Chloride (mmol/L) 113.37 117.80 +/- 117.46 +/-
+/- 3.30 3.34 3.40 
TC02 (mmol!L) N/A 28.63 31.93 
+!- 4.51 +!- 4.21 
Anion Gap (mmol/L) 24.66 10.65 6.94 
+/- 5.38 +!- 6.67 +!- 5.49 
Hematocrit (%PCV) N/A 39.86 39.43 46.01 42.35 
+/- 3.02 +!- 2.34 +!- 9.71 +/-7.10 
Hemoglobin (g/dL} N/A 14.13 14.08 15.63 14.47 
+/-1.09 +!- 0.88 +!- 3.31 +!- 2.38 
pH N/A 7.32 7.34 
+!- 0.07 +!- 0.05 
PC02(mmHg) N/A 52.39 56.32 
+/-7.02 +/-7.10 
HC03 (mmol/L) 21.35 27.08 30.50 
+!- 4.00 +!- 4.36 +!- 3.10 
Base Excess N/A 5.26 4.76 (mmol!L) +!- 0.86 +!- 3.45 
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Blubber Findings from Atlantic Bottlenose Dolphins (Tursiops truncatus) Inhabiting the 
Indian River Lagoon, Florida 
Goldstein J.D., R. A. Varela and G. D. Bossart 
Harbor Branch Oceanographic Institution, Ft. Pierce, FL 
As a part of a five-year comprehensive HERA study, we initiated an investigation 
analyzing blubber thickness and morphology utilizing ultrasonography. The primary 
goal of this study was to develop a non-invasive method of health evaluation, utilizing 
ultrasonography to evaluate differential blubber thickness. In addition, we seek to 
determine the differential blubber thickness at various anatomical locations, as well as 
assess differences between and within geographically distinct populations. Finally we 
plan to compare our findings to previous blubber studies based on blubber samples from 
necropsies as opposed to ultrasonography. It is important to note that this abstract 
represents preliminary data, and no advanced statistical analyses have been conducted at 
this time. 
The images for the study were obtained utilizing a Sonosite 180 ultrasound machine with 
a 5-2 MHz curvilinear probe. An Aquasonic gel pad (standoff) served as an interface 
between the probe and the skin. Due to the challenges of a placing a curved probe on a 
flat surface, the standoff also aided in providing a uniform image. Finally, a 
towel/shaded area or virtual reality glasses were used to overcome the challenges of 
viewing the images in the daylight. Seven locations were selected for imaging (Figure 1). 
Previous studies indicated that the blubber areas cranial to the anus were considered to be 
the most "active". In Koopman eta!., (2002) which examined starved harbor porpoises, 
very little of the overall blubber loss came from the tailstock; more than 92% of the 
cumulative loss occurred cranial to the anus (Koopman et a!. 2002). Sites -t·-6 were 
measured in both 2003 and 2004; and site 7; which is the biopsy site; was measured only 
in 2004. Once the images were obtained, they were analyzed in a controlled environment 
with a laptop computer and specialized software. A full thickness measurement was 
obtained for site 1 (postnuchal fat pad). Internal, external, and total thickness 
measurements were obtained for sites 2-7. 
Thus far, descriptive statistics for clinically healthy animals have been conducted and 
preliminary analyses completed. No adjustments were made based on age, length, weight, 
girth, or gender as of yet. (Figure 2) Based on this preliminary information, several 
observations were evident. Overall, internal blubber layers were thicker than external 
layers for Indian River Lagoon (IRL) and Charleston (CHS) animals. Charleston dolphins 
had higher total blubber thickness than IRL dolphins. Indian River Lagoon postnuchal fat 
pads appeared to be thicker than CHS dolphins. Finally, sites 3 and 5 had similar 
thickness as did sites 4 and 6. 
Further analyses will include standardization for size, comparison of healthy vs. non-
healthy animals, comparisons based on gender, age, and pregnancy status, comparison of 
geographic locations, as well as comparisons to the published literature. In addition, 
32 
studies are also being conducted to evaluate the significance of the postnuchal fat pad 
which is thought to be metabolically different than the other blubber locations. 
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Figure 1. Blubber ultrasound site locations 
2 
1 
3 
4 
Table 1. Comparison of CHS and IRL blubber measurements by site location. Key: I=Intemal Layer, E= 
External Layer, PNF=Post Nuchal Fat Pad. 
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7E 
71 
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6E 
61 
5Total 
5E 
51 
Site 4 Total 
4E 
41 
3 Total 
3E 
31 
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2E 
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PNF 
0 2 3 
PNF 21 2E 2 Total 31 3E 3 Total 41 
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Isolation of a Novel Papillomavirus (Pv) from a Genital Lesion of Dolphin Fb892: 
Tursiops truncatus Papillomavirus Type 2. 
Manuela Rehtanz1"2, S-J Ghim1•2, A. B. Jenson1'2, G. D. Bossarf 
1James G Brown Cancer Center, University of Louisville, KY 
2Harbor Branch Oceanographic Institution, Ft. Pierce, FL 
A novel papillomavirus, Tursiops truncatus Papilloma virus type 2, TtPV -2, isolated from 
a genital lesion of dolphin FB892 was identified by using the isothermal multiply primed 
rolling-circle-amplification technique. The complete nucleotide sequence was determined 
by sequencing transposon integration sites of the cloned viral DNA. A phylogenetic 
analysis revealed that TtPV-2 belongs to the close-to-root sea mammal genus together 
with TmPV -1, PsPV -1 and TtPV -1 with the highest L1 nucleotide sequence similarity to 
TtPV-1 (70%). The L1 nucleotide sequence encoding the major component of the viral 
capsid was identified and cloned. To create VLPs as a vaccine which can be applied to 
captive animals, insect cells were transfected with a baculoviral vector containing TtPV-2 
L1, the coding sequence for the L1 protein of the PV isolated from Tursiops truncatus in 
the Charleston Harbor. 
Antibodies against dolphin Ig were generated in mice, isolated and purified to serve as a 
control in future seroepidemiological studies to screen captive and free-ranging dolphins 
for active infections with TtPV -2. Therefore, antibodies against VLPs will be induced in 
miCe. 
Specimens probably containing Herpes- and Poxviruses, respectively, will be used to 
characterize those viruses, possibly to create vaccines. 
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Development and Standardization of a Suite of Assays to Assess Immunotoxicity in the 
Bottlenose Dolphin 
Margie M. Peden-Adams1•2•3 and Tracy Romano3•2 
1Department of Pediatrics, 2Marine Biomedicine and Environmental Science Center, 
Medical University of South Carolina, Charleston, SC. 3Mystic Aquarium and Institute 
for Exploration, Mystic, CT. 
Increases in the incidence of mass mortality events (MMEs) involving bottlenose 
dolphins (BND) has led to concern over their health. Many of these mortality events are 
thought to be caused by infectious microbes such as morbillivirus and/or biotoxins such 
as brevetoxin. It is unclear if these agents were the primary cause of the MMEs or if 
compromised immunity, related to contaminant exposures, causes increased susceptibility 
to infectious agents. Studies with terrestrial and marine mammals have shown that 
organochlorine contaminants suppress immune function. In the 1980's, the National 
Toxicology Program proposed a two-tiered immunotoxicological testing scheme for 
rodents. Luster et al., (1988) and Weeks et al., (1992) proposed a three tiered testing 
scheme for assessing immunotoxicity in wildlife (reviewed in Keller et al. 2005). Based 
on these testing schemes a suite of assays that do not require in vivo procedures and can 
be performed non-lethally was developed for assessment of immune function in marine 
mammals. The assays chosen encompass measurements that can be conducted from 
blood samples to measure function of iunate, cellular, and humoral immunity (Table 1 ). 
Currently, various labs assess immune function in bottlenose dolphins; however, 
differences in assay methods and collection and storage techniques make comparing data 
from different studies difficult. Standardization and validation of functional immune 
assays are, therefore, required to be able to compare immune function data from different 
dolphin populations collected by various investigators. Thus this study began to 
standardize and validate immune assays proposed in Table 1. Assay validation requires 
that the assays be: 
1. Performed in several labs yielding the same results 
2. Reproducible within a lab and between labs 
3. Specific for the type of immune function being assessed 
4. Able to measure both normal and abnormal function 
5. Able to measure altered function caused by exposure to know immunotoxicants 
6. Undergo peer review 
To begin to standardize and validate the assays for bottlenose dolphin, T- and B-cell 
proliferation using radioactive thymidine were optimized and standardized on paired 
blood samples by two labs. Incubation times, peripheral blood leukocyte collection 
methods, mitogen concentrations and media components were assessed and a Standard 
Operating Procedure (SOP) was fmalized. Proliferation measurements using BrDU are 
currently be optimized for BND. Experiments will then be undertaken to compare the 
results of these two methods on paired samples. Finally, paired experiments in two labs 
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will be undertaken to assess in vitro exposure to known inununotoxicants to determine 
the repeatability of results between labs. 
Table 1. Proposed Comprehensive Screening Set of inunune assays for bottlenose 
dolphin that can be performed on blood samples from non-lethal collections. 
Test Immune Component Comments/Status 
M0 Phagocytosis/ 
Neutrophil phagocytosis 
Innate Available 
M0/ Innate Available (Flow Method-hydrogen 
Neutrophil peroxide)/ Available 
Respiratory Burst ( spectrofluorometer methods-(nitric oxide, hydrogen 
peroxide, superoxide superoxide- NBT reduction)/ 
ProductiOn) Develop nitric oxide assay 
Lysozyme Activity Innate Available 
NK cell Activity Innate Available 
Immunophenotyping CMI Need reagents (anti-CD8, anti-
(CD4, CD8, CD19, CD21, CD16) 
CD2, MHCII, CD16) 
Mixed Lymphocyte Response CMI Needs to be developed' 
(MLR) 
(in vitro) 
CTL activity CMI Needs to be developed' 
(in vitro) 
Lymphocyte Proliferation CMIIHI Available/ method validation 3H vs. 
BrDU required 
Total IgM/IgG HI Available 
Pathogen ELISAs HI Available 
PFC Response 
(M-D in vitro) 
HI Needs to be developed' 
Cytokine Panel All Needs to be Validated 
Stress Hormones General Available 
WBC Differential General Available 
Hematocrit General Available 
'Needs to be developed in this species but has been done in mice and humans. 
CMI= Cell Mediated Immunity, HI= Humoral Immunity 
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During the HERA live captures in 2003 two phagocytosis methods were assessed: 
Listeria uptake (Staining and counting via microscope) and a flow cytometric assay 
assessing E. coli phagocytosis. These assays when assessed in relation to sampling 
locations yielded the same results. During the 2004 HERA live capture, respiratory burst 
was assessed by two methods (superoxide flow cytometry method and NBT reduction 
measuring hydrogen peroxide). Although these assays did not correlate with each other, 
when assessed statically in relation to the study locations they yielded the same results. 
The lack of correlation between the measurements of these two different free radicals is 
not necessarily unexpected as the production rates of these upon cell stimulation are not 
clear and may not be 1: 1. Regardless, the data showed that either method could be used to 
assess respiratory burst and that the same conclusion as to the differences between 
locations would be made. As contaminant data from these captured animals becomes 
available, these different methods will be correlated against specific contaminant class to 
determine if they yield similar relationships. 
NK cell activity was optimized for two different methods (Cr51 release and flow 
cytometric analysis). These studies tested two target cell lines (K562 and Y ac-1 ). Based 
on studies in beluga whales (DeGuise et al., 1997), it was expected that K562 cell line 
would be the better target for the assay. Studies with both methods, however, revealed 
that for bottlenose dolphins Y ac-1 cells are better targets. These two assays will be 
compared between labs following in vitro exposure to known immunotoxiciants. 
Studies assessing sample collection and storage were also undertaken to determine the 
similarity of results between fresh vs. frozen cells. Cell viability was assessed in several 
different types of freezing media. Origen medium from Fisher yielded slightly higher cell 
viability (although not statistically) than 90% FBS/10% DMSO. For freezing 
experiments, lymphocyte proliferation (measured with 3H-thymidine) and NK cell 
function (CR51 release) wereassessed on fresh (24hr old) cells. Peripheral blood 
leukocytes (PBLs) collected and assessed for proliferation and NK cell activity were then 
frozen at 2e7 cells/mL in Origen medium for one month. Frozen cells did not function in 
the Cr51 NK cell assay. Preliminary experiments suggest that PBLs frozen in 90% 
FBS/10% DMSO do function in the Cr51 release assay. Further studies need to critically 
assess this function in fresh cells as compared to cells frozen in 90%FBS/10%DMSO. 
Lymphocyte proliferation in cells frozen in Origen medium were assessed at three 
concentrations of Con A (T -cell mitogen) and LPS (B-cell mitogen). Frozen results have 
not been correlated to fresh results to date but will be. However, at optimum 
concentrations of each mitogen (ConA 2.5 J.Lg/mL and LPS at 120 J.LglmL), there were no 
significant differences between the mean of the samples assessed fresh and the mean of 
the same sample assessed frozen. At sub- and super- optimum concentrations the means 
were different from the fresh samples but this was only statistically significant for the 
sub-optimal concentration ofLPS (60 J.Lg/mL). Further studies are required to assess a 
frozen time course to determine how long PBLs can be frozen and still yield similar 
results in the proliferation assay. 
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Ongoing studies are assessing the feasibility of an in vitro antibody production assay 
(plaque forming cell response). Validation oflysozyme activity between two labs will 
occur in summer 2005 and NK cell activity will be compared in samples using flow 
cytometry and Cr51 release using samples from the HERA 2005 captures. Final 
validation ofthe immune assays will lead to finalized SOPs. Optimization, 
standardization, validation, and development of formalized SOPs for immune 
measurements will allow better assessment of immune status and comparison of immune 
status between bottlenose dolphin live capture studies in the future. 
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Lymphocyte Proliferation, NK-cell Activity, and Lysozyme Activity in Free-Ranging 
Bottlenose Dolphins Captured as Part of the Health and Risk Assessment Project: 
Preliminary Data Summary 2003 and 2004 
Margie M. Peden-Adams1'2'3, J. EuDaly1•2, L. Heesemann2, M. Lee1'2, and T. Romano3•2 
1Department of Pediatrics, Medical University of South Carolina, Charleston, SC, 
2Marine Biomedicine and Enviromuental Science Center, Medical University of South 
Carolina, Charleston, SC. 3Mystic Aquarium and Institute for Exploration, Mystic, CT. 
Immune function is important to the health and ability of marine mammals to survive. 
Therefore, as part of the Bottlenose Dolphin Health and Risk Assessment (HERA) 
Project conducted by the National Ocean Service and Harbor Branch Oceanographic 
Institution, lymphocyte proliferation, natural killer (NK) cell activity, and plasma 
lysozyme activity was assessed from blood samples collected during live capture-release 
events conducted in Indian River Lagoon, FL and Charleston, SC during the summers of 
2003 and 2004. Blood samples were collected and shipped cool, overnight for analysis. 
Differences between locations were noted both years and the trends between locations 
differed between years based on differences in numbers of animals/gender. 
B-cell proliferation (LPS-induced) was measured by stimulating cells and assessed 3H-
thyrnidine incorporation. Preliminary data, with both years combined suggests there was 
no significant difference in response between locations, although 2003 data indicated that 
animals in IRL had lower B-ee!! function than those in CHS this was not seen in 2004 
data and did not show up when data was combined for both years. Males typically 
exhibited lower B-cell proliferation than did females and this was significantly different 
within locations, but nofbetween locations. With both years combined, females captured 
in the south part ofiRL had lower B-cell proliferation than did females in the northern 
part ofiRL, but this was not statistically significant. 
T-cell proliferation (ConA-induced) was not significantly different in 2003 data between 
locations but was in 2004. In 2004 data, females from the IRL had lower T -cell 
proliferation than did females from CHS (for both pre and post samples). When the data 
was combined for both years, males had significantly lower T -cell proliferation than did 
females within locations. The only significant difference between CHS and IRL, when 
both years were combined, was in female post samples. T -cell proliferation in post 
samples from IRL were lower than post samples from CHS. Caution should be taken 
with this difference, however, as data has not been adjusted for differences that may have 
occurred in elapsed time between pre and post sampling for individual animals. With 
both years combined, males captured in the south part of IRL had significantly lower T-
cell proliferation than did males in the northern part of IRL. 
NK-cell activity was measured by a standard Cr51 release assay. Preliminary data from 
2003 suggests there were no differences in NK-cell activity within or between locations. 
In 2004, females from IRL had significantly lower NK-cell activity than females from 
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CHS. With both years combined, females from IRL had lower NK-cell activity than 
females from CHS, but this was not statistically significant. There was no difference 
between North and South IRL. 
Plasma lysozyme activity was significantly higher in animals captured in IRL than in 
CHS in the summer of 2003. This paralleled significantly increased monocyte 
phagocytosis in IRL as compared to CHS in 2003. In 2004, lysozyme did not differ 
between locations (nor did phagocytosis); however, with both years combined, males in 
IRL had significantly higher lysozyme activity than did males in CHS. There was no 
difference between North and South IRL. 
A preliminary assessment of relationships between hormones and immune function 
revealed that significant correlations were observed with thyroid hormones and estradiol 
and that the relationships were what would be expected from published effects in rodents. 
Associations with perfluorinated contaminant (PFAs) measurements were also conducted 
(Table 1 ). Stronger correlations were observed in some cases when data was assessed by 
location and/or by gender/location (data not shown). Additionally, select PFAs not 
summarized in Table 1 also showed strong correlations with immune parameters 
(Figure 1). 
Table 1. Brief summary of Spearman rank correlations (Rs) between B-cell proliferation 
(lps120 and lps60) and plasma lysozyme activity in relation to select perfluorinated 
compounds (PFOS and PFOA) and the summed total of all PF As measured. 
All Animals All Females All Males 
Health 
ComQound Parameter n Rs n Rs n Rs 
PFOS lps120 84 0.2692 26 0.3908 58 0.199 
lps60 84 0.347 26 0.345 58 0.3293 
lysozyme 89 -0.3404 29 -0.1941 60 -0.3995 
PFOA lps120 84 0.2662 26 0.4069 58 0.2039 
lps60 84 0.3432 26 0.3525 58 0.3456 
lysozyme 89 -0.3647 29 -0.3146 60 -0.4052 
LPFA lps120 84 0.2722 26 0.4202 58 0.1998 
lps60 84 0.3519 26 0.3709 58 0.3373 
l~soz~me 89 -0.3846 29 -0.22 60 -0.4326 
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Figure 1. Spearman ranked correlations (Rs) for some specific parameters not 
summarized in Table 1. 
In conclusion, preliminary data suggests differences in immunity within and between 
capture locations. The differences vary with capture year; therefore, alterations in 
environmental and health parameters between years should be assessed. As expected 
immunity exhibited relationships with plasma hormone levels. These relationships need 
to be further explored in relation to pre and post sampling and time elapsed between these 
samplings. Finally, data suggest for the fist time that immunity in wildlife may be 
modulated by exposure to PF As. This needs to be followed with in vitro exposures and 
rodent dosing experiments and will be further clarified as the 2004 PF A data becomes 
available. 
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Assessment oflmmune Function in Wild Bottlenose Dolphins (Tursiops truncatus) Live-
Captured in the Indian River Lagoon, Fl and Charleston, SC 
Tracy Romano1, A. Linton1•2, M. J. Keogh3, D. Beal1, M. Peden-Adams4, G. D. Bossart5, 
and P. A. Fair6 
1 Department of Research and Veterinary Services, Mystic Aquarium and Institute for 
Exploration, Mystic, CT; 2Department of Microbiology, Immunology, and Pathology, 
Colorado State University, Fort Collins, CO; 3Department of Veterinary Anatomy & 
Public Health, Texas A&M University, College Station; 4Marine Biomedicine and 
Enviromnental Science Center, Medical University of South Carolina, Charleston, SC; 
5Harbor Branch Oceanographic Institute, Ft. Pierce, FL; ~OAA/NOS/CCEHBR 
Charleston, SC 
The Bottlenose Dolphin Health and Risk Assessment (HERA) Project is a major 
collaborative effort involving a number of individuals and institutions. The study was 
designed to collect and analyze various health parameters from bottlenose dolphin 
populations in the Indian River Lagoon (IRL), FL and Charleston Harbor (CHS), SC. 
Resident populations in these two regions are exposed to various contaminants and 
enviromnental stressors that may potentially lead to immunosuppression and increased 
risk of illness and disease. Therefore, immune function was evaluated as part of an 
overall health assessment. The primary pnrpose of this study was to specifically assess 
immune function in free-ranging bottlenose dolphins live-captured in the Indian River 
Lagoon, FL, and Charleston, SC as part of the HERA Project. 
After capture, blood samples were obtained both initially upon restraint (pre sample), and 
immediately before release into the wild (post sample). Flow cytometry was used to 
quantifY peripheral blood lymphocyte subsets and to assess neutrophil and monocyte 
phagocytosis and respiratory burst. Cetacean-specific antibodies or antibodies shown to -
cross-react with dolphin counterparts from other species were used to quantifY 
lymphocyte subsets. Absolute numbers and percentages were quantified for dolphin T 
and B lymphocytes, T helper and MHC class II positive cells. Two fluorophores were 
used to simultaneously measure phagocytosis and respiratory burst in dolphin neutrophils 
and monocytes. Propidium iodide-labeled Staphylococcus aureus (ATCC 14923) 
(wavelength of 585mn) was used to measure phagocytized bacteria, and 2', 7'-
dichlorofluorescein diacetate (DCFDA), a non-fluorescent cell permeable dye which 
upon oxidation becomes fluorescent (wavelength of 525mn) was used to measure 
respiratory burst activity. Percent phagocytosis and mean fluorescence intensity (MFI) 
for respiratory burst activity were measured in whole bottlenose dolphin blood. Data 
from 2003 and 2004 for each location was combined and analyzed within each individual 
population with respect to sex (male/female) and location (north/south region of the IRL), 
and then analyzed between IRL and CHS populations. Immune data has been 
preliminarily analyzed with other data sets such as stress and reproductive hormones, and 
contaminants such as perfluorinated compounds. Preliminary statistical analyses were 
carried out at P<0.05. 
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In the IRL, males had significantly higher TIT helper cell ratios than females, while 
males in CHS had significantly higher neutrophil phagocytosis than females in CHS. 
Those animals sampled in the North of the IRL showed significantly higher B cells than 
those dolphins in the South IRL, along with higher T cell and MHC II percentages than 
those in the South. In parallel with the above findings, those animals in the South 
showed greater T!B cell ratios than those dolphins in the North IRL. Moreover, the 
absolute numbers oflymphocyte subsets in males of the North IRL were significantly 
higher than males in the South IRL. The T/B and T/T helper ratios offemales in the 
South IRL were higher than the females in the North. When comparing the IRL vs. CHS 
population, B cells in CHS females are significantly higher than females in the IRL and B 
cells and T helper cells are higher in CHS males than IRL males. The T!B ratios ofiRL 
males and females are higher than CHS males and females. Neutrophil phagocytosis is 
higher in IRL females than CHS females. Positive correlations (P<0.05) were observed 
with T helper cells, T and B cell percentages, and T 1B ratios with testosterone and 
estradiol; negative correlations were observed with ACTH and B cell percentages, 
aldosterone and T , MHC II percentages, dopamine and epinephrine and T helper, B cell 
percentages and MHC II+ cells. Perfluorinated compounds showed a positive correlation 
with T, B, T helper, and MHC II+ cells. 
It was determined at the first HERA Project review meeting last February that in order 
for conclusions to be drawn from the immune data that we need a starting data set of 
"healthy" animals identified by veterinary observations and body condition (Tier I) and 
CBC/serum chemistries (Tier II). Furthermore, data should be analyzed both 
categorically and statistically in a consistent manner among data sets. The data will be 
reanalyzed once this information is available and conclusions drawn in order to provide a 
"complete" health assessment of the bottlenose dolphin populations in the IRL and CHS. 
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Serum Biomarkers of Immune Function in Bottlenose Dolphins Inhabiting the Indian 
River Lagoon, FL and Charleston, SC 
Charles Rice, Ph.D. Clemson University, Clemson, SC 
Key monoclonal antibody (mAb) reagents have been developed in our laboratory 
that allow for the detection and quantification of both total and specific IgG in bottlenose 
dolphin (Beck and Rice, 2003). Two mAb antibodies (BBl0-2 and BB32-2) were 
generated against bottlenose dolphin IgG previously purified using protein-G columns. 
In addition, rabbit polyclonal antisera was generated against this same IgG preparation. 
Antibody (IgG) levels specific to a particular pathogen can be quantified by indirect 
ELISAs using either of the mAbs, while total IgG levels can be measured by capture 
ELISAs using both mAbs or by using one mAb to capture IgG and the polyclonal anti-
sera for detection. Serum samples from individual bottlenose dolphins were collected 
during live captures at Indian River Lagoon, FL and Charleston Harbor in 2003 and 2004 
by NOAA field specialists. Serum samples were then sent to Clemson University where 
upon the ELISAs were performed. No differences in total IgG were detected between the 
two field sites in both years. In 2003 no differences in bacteria-specific antibody levels 
between the two sites were detected. However, several differences in antibody levels 
against specific bacteria could be detected in 2004. Indian River Lagoon females had 
lower antibody levels against Erysipelothrix rhusiopathiae than did males sampled in the 
Charleston Harbor. Males sampled from the Indian River Lagoon had higher antibody 
levels specific for Mycobacteria marin urn, but lower levels of antibody specific to Vibrio 
vulnificus. 
We are currently in the process of validating in-hand mAbs and polyclonal 
antibodies generated against bottlenose IgM purified using Hi-Trap columns (Pharmacia). 
Unfortunately, this method oflgM purification also co-purifies a certain fraction oflgG, 
thus which of our mAbs are specific for IgM and whether or not the polyclonal is specific 
for IgM is not clear. An in vitro transcription-translation system (rabbit reticulocyte 
lysate) that expresses a cloned bottlenose dolphin IgM fragment (generous gift from Dr. 
Greg Warr) is currently being used to screen our antibodies. If neither of our antibodies 
are specific for the clones IgM fragment then we will express this fragment as a 
recombinant protein to then generate more anti-IgM antibodies. Having IgM-specific 
reagents will allow us to quantify both pathogen-specific and total IgM in archived 
serums samples collected in 2003 and 2004. 
Circulating acute phase proteins such as c-reactive protein (CRP) are indicative of 
early or persistent inflammation, thus should serve as a key biomarker of any ongoing 
inflammation. An in-hand mouse anti-sera generated against sharpnose shark (Karsten 
and Rice, 2004) recognizes a serum protein in bottlenose dolphins indicative of CRP (i.e., 
25 kD denatured). Using standard indirect ELISAs, no differences between Indian River 
Lagoon and Charleston Harbor bottlenose dolphin CRP levels were detected, however 
CRP levels in select individuals were quite high. Lysoyzme protein levels were 
examined during 2004 using an in-hand pan-lysozyme-specific mAb (M24-2). No 
differences between sites or genders were detected. We did not, however, examine 
lysozyme activities in these serum samples. 
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Characterization of Bottlenose Dolphin Cell Activation Using Monoclonal Antibodies 
Sylvain De Guise, C. Mori, B. Morsey, and M. J. Levin 
Department ofPathobiology and Veterinary Science, University of Connecticut, Storrs, 
CT 
The immune system is central in health and one of the most susceptible systems to the 
effects of exogenous stressors. The complexity of the marine mammal immune system 
and its susceptibility to different types of stressors are increasingly studied and slowly 
unraveled. The present study consisted of using new methods to assess the expression on 
blood leucocytes of molecules known to be inducible upon cell activation, in order to 
possibly assess the level of activation in dolphins from different locations. The 
expression of the beta-2 integrin CD11/CD18 (using a cetacean-specific monoclonal 
antibody) as well as that of the pattern recognition receptors CD14, TLR2 and TLR4 
(using cross-reacting antibodies to the human molecules) was assessed in different cell 
types using flow cytometry. CD11/CD18 was expressed on 7 +/- 5% (standard 
deviation), 11 +/- 6% and 1.5 +/- 2% of neutrophils, monocytes and lymphocytes, 
respectively, with ranges of 1-26%, 0-31% and 0-9%, respectively. CD14 was generally 
expressed on less than 1% ofleucocytes of all types. TLR2 and TLR4 were both 
expressed on generally less than 1% of neutrophils and lymphocytes, and on 3 +/- 9% 
and 1 +/- 4% ofmonocytes, respectively. Expression of those molecules was not 
increased by a short-term in vitro stimulation. The expression of CD 14 in monocytes and 
lymphocytes and that ofCDll/CD18 in neutrophils were lower in Charleston than in the 
IRL when data from both years were combined (CD14) or using only the 2003 data 
(CD11/CD18). In contrast, the expression ofTLR4 in neutrophils and lymphocytes was 
higher in Charleston than in the IRL in 2004. There were no differences between sexes in 
the expression of those molecules. Overall, the expression ofCD14, TLR2 and TLR4 was 
detected for the first time in leucocytes from bottlenose dolphins, and the expression on 
the surface of leucocytes of molecules whose expression is induced upon activation may 
prove to be a useful tool in further health assessment of wild and captive populations of 
marine mammals. 
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Organochlorine Pesticides, Polychlorinated Biphenyls and Polybrominated Diphenyl 
Ethers in Dolphins from the Indian River Lagoon, Fl and Charleston, SC 
Patricia A. Fair and Gregory Mitchum 
NOAA/NOS/CCEHBR, Charleston, SC 
Persistent organic contaminants (POCs), including organochlorine pesticides (OCPs), 
polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PEDEs), are 
ubiquitous pollutants in coastal environments and are of significant concern due to their 
high toxicity and long environmental half-lives. Many POCs have the potential to induce 
toxicological impacts on both wildlife and humans (Jones and de Voogt 1999). Over the 
last several years, it has become clear that PEDEs and other flame retardant chemicals 
have joined PCBs, DDT and dioxin on the list of persistent, bioaccumlative chemicals. 
These PEDEs have been found in tissues of a wide range of animals, including marine 
mammals (Aguilar et al. 2002) and humans, with levels in breast milk of U.S. women 
highest in the world (Betts 2002, Schecter et al. 2004, She et al. 2004). Potential health 
risks ofPBDEs for marine mammals include endocrine disruption in grey seals (Hallet 
al. 2003). On a global scale, evidence for declining concentrations of traditional POCs, 
such as PCBs and DDT, are occurring in some marine systems, while increasing levels of 
PEDEs and other emerging contaminants highlight the need to monitor marine mammals 
and the environment (de Wit 2002, Houde et al. 2005). These compounds were measured 
in blubber biopsy samples collected during the summer of 2003 from dolphins in the 
Indian River Lagoon (IRL), FL and Charleston (CHS), SC using GC/MS techniques. 
Full-depth biopsies were surgically removed from the left side of the animal at a site 5-10 
em caudal to the dorsal fin and 10 em ventral to the dorsal ridge and placed immediately 
in a liquid nitrogen dewar. 
POC analytes were measured in blubber samples from a total of 72 dolphins (38 CHS, 34 
IRL). Measurements included 71 PCB congeners (1, 2, 3, 5/8, 9, 12, 15, 18, 20, 26, 
28/31,29,37,44, 45,48, 49, 50, 52, 56/60,61/74, 63, 66, 69, 70/76, 77, 82, 84, 87/115, 
88/95, 89, 92, 99, 101/90, 105, 106/1181123, 1071108, 101/90, 110, 114, 119, 123, 126, 
128/167, 130,132/153/168,141,146,149,151, 154, 159, 169, 170/190,172,174, 177, 
180, 183, 187, 188, 189, 193, 194, 195,200,201, 202,206,207, and 209), and 20 
pesticides (2,4'-DDD, 2,4'-DDD, 2,4'-DDE, 2,4'-DDT, 4,4'-DDD, 4,4'-DDE, 4,4'-DDT, 
Aldrin, Beta-HCH, Cis-chlordane, Cis-nonachlor, Dieldrin, Endosulfan I, Endosulfan II, 
Endosulfan Sulfate, Gamma-chlordane, Heptachlorepoxide, Hexachlorobenzene, Mirex, 
and Trans-nonachlor) and 6 PBDE congeners (28, 47, 99, 100, 153, and 154). 
Analysis of total PCBs were reported in Table 1 by the following age categories: adult 
males 15 yrs and older; adult females 7 yrs and older and juveniles were characterized as 
less than these ages; pregnant females were also grouped. Consistent with many other 
marine mammal studies, concentrations ofPCBs were highest in male dolphins and 
lowest in females of reproductive age (Aguilar et al., 2002). The mean concentrations of 
PCBs and pesticides varied among age categories with fewer differences seen among the 
two sites. The total PCB data in Table 1 were based on our recently expanded analysis of 
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71 PCB congeners. These results, when compared to our previous published values on 
CHS and IRL animals, which assessed total PCB based on only 28 congeners (Hansen et 
al. 2004), found similar values which were approximately less than 50% of the total PCB 
concentrations measured using 71 congeners. Total DDT was greater for all CHS 
dolphins (22,570ng/g; n=38) compared to IRL dolphins (19,755ng/g; n=34) but age 
categories comparisons were similar to that for the PCB data. 
Table I. Total PCBs (ng/g lipid) in Blubber Samples 2003 
Total #of Mean (± Std Dev) Minimum Maximum Median 
PCBs animals 
Age CHS IRL CHS IRL CHS IRL CHS IRL CHS IRL 
cate~orv 
Juvenile 10 14 64,634 62,078 28,575 22,763 100,219 192,649 59,006 50,506 
Male (23,426) (46,102) 
Juvenile 3 3 43,687 36,686 30,628 9,282 52,892 55,916 47,541 44,859 
Females (11,621) (24,367) 
Adult 16 10 117,378 113,867 59,796 41,710 255,010 227,291 88717 100,086 
Males (63,564) (59,935) 
Adult 5 3 8,787 10,210 4,538 1,520 12,209 20,099 8,907 9,011 
Females (2,745) (9,347) 
Pregnant 4 3 16,273 29,582 7,788 14,852 35,073 39,935 11,115 33,959 
Females (12,631) (13,102) 
While the distribution pattern of blubber PEDEs were similar among dolphins at both 
sites, the CHS animals had higher total PEDEs (sum of28, 47, 99, 100, 153, and !54) in 
their blubber tissue. Male dolphins in CHS had mean concentration of 2,994 ng/g lipid 
(±1,193 SD) compared to 1,275ng/g lipid (±855 SD) in IRL male dolphins. In all age 
categories adult females in both the IRL and CHS sites had the lowest PBDE 
concentrations (CHS mean concentration 363±127ng/g lipid; IRL mean concentration 
693±800ng/g lipid). CHS juvenile dolphins, both females and males, also had 3-4X 
higher concentrations than IRL juvenile male and female dolphins with the juvenile male 
dolphins near the same levels as in adult males which are among the highest levels found 
in marine mammals. The distribution pattern ofPBDE congeners were similar for both 
sites with 4 congeners comprising 98% of all PEDEs measured for CHS and 94% for 
1RL as follows: PBDE100>PBDE154>PBDE99>PBDE47. PBDE 100 was the largest 
component for both the IRL and CHS dolphins (51% CHS; 42% PEDEs) followed by 
PBDE 154 (CHS 24%; IRL 23%), then PBDE 154 (24%CHS; 23%) and PBDE 99 
(13%CHS; 15%IRL). 
Preliminary descriptive statistics conducted on 2003 POC blubber concentrations in IRL 
and CHS dolphins are presented. The high body burden of complex mixtures ofPOCs, 
including PCBs, DDT, DDE and PEDEs, carried by these populations of dolphins and the 
known toxicities of many of these compounds may pose a significant health risk. The 
POC 2004 blubber data for IRL and CHS dolphins will be available spring 2005 and 
further analysis will include comparison to 2003 data and examining the relationships 
between POC blubber concentrations with POC plasma concentrations, thyroid level and 
biomarkers of immune functions as well as other health parameters. 
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Emerging Contaminants (Perfluoroalkyl Compounds and Hydroxylated-PCBs) in 
Bottlenose Dolphins from Charleston, SC and the Indian River Lagoon, FL 
Magali Houde1•2, P. Fai2, G. B. Bossart4, K. Solomon1, D. Muir1•2 
1University of Guelph, Ontario, Canada; 2National Water Research Institute, 
Environment Ontario, Canada; National Oceanic and Atmospheric Administration, NOS 
Center for Coastal Environmental Health and Biomolecular Research, Charleston, SC; 
4Division of Marine Mannnal Research and Conservation, Harbor Branch Oceanographic 
Institution, Ft. Pierce, FL 
As part of the HERA dolphin project, two main groups of emerging contaminants, 
perfluoroalkyl compounds and hydroxylated polychlorinated biphenyls (OH-PCBs), were 
assessed for the first time in free-ranging bottlenose dolphins. Perfluoroalkyl compounds 
(PF As) have been used for decades in a variety of industrial and commercial products 
such as stain repellents, paints, polishers and fire-fighting foams. Perfluorinated 
carboxylic and sulfonic acids are persistent PFA degradation products known to affect 
development, peroxisome proliferation and cell-to-cell communication in rodents. OH-
PCBs are metabolic PCB degradation products that are known to have thyroidogenic 
effects. Our objectives were to assess the PFA, PCB and OH-PCB concentrations in 
dolphin's plasma as well as look at the potential PFA bioaccumulation through the 
dolphin's food web by analyzing water, sediment and fish samples. A PFA body 
distribution was also assessed by analyzing tissues of a female dolphin from Charleston. 
Results show that high PF A levels, including high concentrations of perfluorooctane 
sulfonate (PFOS), were detected in plasma of animals from both populations. PF A 
concentrations detected in Charleston dolphins were higher that any report published to 
this date. PF As were detected in all tissues analyzed with the highest levels found in 
liver, lung and thyroid. PFAs were also detected in sediment and fish. Prey/predator ratio 
suggests possible bioaccumulation and biomagnification ofPFA in the dolphin's food 
chain. An extraction method is presently being tested for water sample extraction. 
Preliminary results for PCB showed that plasma levels were higher at Charleston 
compared to Indian River Lagoon (IRL). Numerous OH-PCBs were also detected in 
dolphin plasma from both locations with higher levels detected in animals from IRL 
compared to Charleston. PCB pattern of contamination were similar between populations 
but varied for OH-PCBs. Relationships between PFA plasma concentrations and 
biomarkers ofinunune functions, as well as PCB/OH-PCB levels and hepatic enzyme 
activities, respectively, will be investigated. 
50 
Changes in Gene Expression in the Skin-Blubber Biopsy as Measures of Chemical 
Exposure and Effect in the Bottlenose Dolphin (Tursiops truncatus) 
Montie, E. W. 1'2, S. R. Garvin1, P. A. Fair3, G. D. Bossart4, A. A. Hohn5, G. B. 
Mitchum3, W. E. McFee3, M. J. Moore1, and M. E. Hahn1• 
1Woods Hole Oceanographic Institution, Woods Hole, MA; 2Massachusetts Institute of 
Technology, Cambridge, MA; 3NOAA, National Ocean Service, Charleston, SC; 4Harbor 
Branch Oceanographic Institution, Ft. Pierce, FL; ~OAA, National Marine Fisheries 
Service, Beaufort, NC 
Background and Objectives. In support of the Bottlenose Dolphin Health and Risk 
Assessment (HERA) Project, our research goals were to assess changes in gene 
expression (in the skin-blubber biopsy) as measures of chemical exposure and effect. 
Cytochrome P4501Al induction is a valuable biomarker of exposure to planar 
halogenated aromatic hydrocarbons (PHAHs) and has been used extensively in fish, 
birds, and marine mammals. Its advantages include the extensive literature 
demonstrating its relationship to PHAH exposure, the relatively robust methods that exist 
for its detection, and the fact that it can be measured in skin-blubber biopsy samples. 
Thus, our primary objective was to measure cytochrome P450 lAl (CYPlAl) expression 
in bottlenose dolphin skin-blubber biopsy samples from i) Charleston, SC; ii) Titusville, 
FL (IRL-N); (iii) and Stuart, FL (IRL-S) sites. The initial CYPlAl analysis of stained 
sections revealed that blubber morphology and CYPlAl expression were highly variable 
with blubber depth. Consequently, our research goals expanded to provide a histological 
assessment of blubber stratification in these live-captured dolphins and to quantitatively 
test the hypothesis that CYPlAl expression varies with depth in dolphin blubber. 
Despite the value of CYPlAl as a measure of chemical exposure, its value as a 
biomarker of adverse effect is debated, because its mechanistic link to PHAH toxicity is 
uncertain. There is a need for new biomarkers of PHAH effects, especially ones that are 
more directly linked to toxicity. Thus, an additional objective was to explore the 
feasibility of using suppression subtraction hybridization (SSH) to identify novel 
biomarkers (genes) for measuring chemical exposure in skin-blubber biopsies. 
There is also evidence that certain PHAHs can interfere with the thyroid hormone system 
in rats, humans, and seals and cause hypothyroxinemia (low thyroxine or T4). Thus, in 
addition to the use ofCYPlAl and research to develop novel biomarkers ofPHAH 
toxicity, we began to explore possible biomarkers of thyroid hormone status, in particular 
Type II 5'-deiodinase (or D2). D2 activates the prohormone T4 to form the active 
hormone T3. Observations have led to the theory that D2 produces T3 for local cellular 
demands, independent of circulating T3. D2 expression also increases with 
hypothyroidism. Thus, another objective was to explore the feasibility of measuring D2 
in skin-blubber biopsies as a biomarker of thyroid hormone homeostasis. 
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Results- Blubber Morphology and CYP JAJ Expression. We used established 
histological and immunohistochemical methods to understand the structure of blubber 
and to assess the expression ofCYPlAl in skin-blubber biopsies of bottlenose dolphins 
(Tursiops truncatus) captured in the waters of Cape May, NJ (n=4), Charleston, SC 
(n=38), and Indian River Lagoon, FL (n=36) during the summer of 2003. Histological 
analysis of blubber revealed stratification of the blubber into three layers: a superficial 
layer (very high density of structural fibers and few adipocytes), a middle layer (more 
and larger adipocytes, and fewer structural fibers), and a deep layer (increased structural 
fiber densities and smaller adipocytes). Histological analysis also revealed individual and 
site-specific variability in structural fiber densities, adipocyte numbers, and adipocyte cell 
sizes among dolphins sampled at the three sites. New Jersey dolphins had more and 
larger adipocytes and lower densities of structural fibers than CHS and IRL dolphins. 
We plan to investigate other sources of variability in blubber morphology including sex, 
development, pregnancy, lactation, nutritional status, and disease effects. 
CYP 1 Al expression was strongest and most frequent in capillary endothelial cells within 
the blubber, similar to findings in other studies of cetacean CYPlAI. CYPlAl 
expression differed among the blubber layers: deep blubber layer> middle blubber layer 
>superficial blubber layer (p < 0.001). CYPlAl expression was greater in Charleston 
versus Indian River Lagoon bottlenose dolphins (p = 0.011). Males had higher CYPlAl 
expression than females in the deep blubber layer (p < 0.001). Chemical analysis of 
biopsies and plasma are underway in the labs of Greg Mitchum and Derek Muir. When 
these data become available, we will determine the relationship between CYPlAl 
expression and concentrations of non-ortho and mono-ortho PCBs in plasma and blubber 
of individual dolphins. In addition, we will assess the relationship between CYPlAl 
expression and plasma levels of hydroxylated metabolites of PCBs. We also plan to 
determine ifCYPlAl expression in the middle and deep blubber layers is higher in thin 
dolphins compared to robust individuals. 
SSH Experiments. To begin to identify novel PHAH-regulated genes, we exposed 
dolphin skin/blubber biopsies to PCB-126, isolated RNA, and measured changes in gene 
expression. Initially, we measured the expression ofCYPlAl, to verify that the in vitro 
exposure had been effective at activating the AHR and inducing a known AHR-regulated 
gene. To do this, CYPlAl (370 bp) and actin (1200 bp) eDNA fragments were amplified 
by RT-PCR (from FB814), cloned, and sequenced. The bottlenose dolphin CYPlAl 
amino acid sequence showed 99% identity to striped dolphin (Stene/la coeruleoalba) 
CYPlAl, 89% identity to pig (Sus crofa) CYPlAl, 87% identity to the mouse (Mus 
musculus) CYPlAl, and 86% identity to human (Homo sapiens) CYPlAI. The slice 
treated with PCB-126 showed elevated CYPlAl expression compared to the DMSO-
treated slice, while actin expression did not differ with treatment. These results indicate 
that the in vitro biopsy dosing technique was effective in inducing AHR-dependent gene 
expressiOn. 
As part of the HERA 2004 project, we plan to follow-up these initial results. We have 
designed primers for conducting real-time, quantitative RT-PCR analysis ofCYPlAl and 
actin expression. Using these primers, we will measure the expression ofCYPlAl and 
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actin in all DMSO- and PCB-126-treated slices. The biopsy samples demonstrating the 
greatest CYPlAl induction in these assays will be used in SSH to identify novel PHAH-
responsive genes. 
Type II 5'-deiodinase (D2). To begin to determine the feasibility of measuring D2 as a 
biomarker of thyroid hormone homeostasis, we isolated total RNA from a skin-blubber 
biopsy (from FB814). A D2 (750 bp) eDNA fragment was amplified by RT-PCR (from 
FB814), cloned, and sequenced. The bottlenose dolphin D2 amino acid sequence showed 
92% identity to pig (Sus crofa) D2, 89% identity to human (Homo sapiens) D2, 90% 
identity to the mouse (Mus musculus) D2, and 89% identity to rat (Rattus norvegicus) D2. 
As part of the HERA 2004 project, we plan to follow-up these initial results. We have 
designed primers for conducting real-time, quantitative RT-PCR analysis ofD2 and actin 
expression. Using these primers, we will measure the mRNA expression ofD2 and actin 
in the 2003 skin-blubber biopsies. Wben the data become available, we will determine 
the relationship between D2 expression and concentrations of non-ortho and mono-ortho 
PCBs in plasma and blubber of individual dolphins. In addition, we will assess the 
relationship between D2 expression and plasma levels ofhydroxylated metabolites of 
PCBs. We are also interested in the role that D2 plays in blubber dynamics. [Supported 
by NOAA and by an EPA STAR Graduate Fellowship]. 
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Development of a Dolphin CDNA Microarray 
Annalaura Mancia1, M. Lundqvist1, T. Romano2, G. Bossart3, P. Fair4, and G. W. Warr1 
1Marine Biomedicine and Environmental Sciences Center, Medical University of South 
Carolina, Charleston SC; 2Mystic Aquarium and Institute for Exploration, Mystic CT; 
3Harbor Branch Oceanographic Institution, Inc., Fort Pierce, FL.; 4CCEHBR, National 
Ocean Service, Charleston SC 
The Atlantic bottlenose dolphin (Tursiops truncatus) has been proposed as a sentinel 
species for the health of the marine environment. Dolphins, as top predators, are sensitive 
to the biointensification effects of marine toxins, pollutants and infectious disease agents. 
A number of dolphin pathogens have been described, including morbilli virus, 
caliciviruses and a significant number of human pathogens. The aim of this project is to 
generate molecular tools to assess the health of wild dolphins, thereby indicating the 
status of the local marine environment and providing information for marine resources 
management. Random Expressed Sequence Tag (EST) clones have been isolated and 
sequenced from dolphin Peripheral Blood Leukocyte (PBL) eDNA libraries. Genes 
known to be important in the innate and adaptive immune responses of terrestrial 
mammals and in responses to stress and contaminant exposure have been targeted for 
cloning using PCR-based techniques. We have cloned approximately 2200 unigenes from 
the dolphin eDNA libraries and 62 dolphin genes of known stress or immune function by 
targeted PCR (www.marinegenomics.org). These genes, together with other genes 
randomly selected without sequencing from the eDNA libraries, have been amplified and 
used to construct a eDNA rnicroarray representing 3700 dolphin genes. The dolphin 
eDNA rnicroarray will be used to analyze PBL RNA from captive dolphins of known 
health status with the aim to validate and optimize the eDNA rnicroarray as a sensitive 
and informative tool. The dolphin eDNA rnicroarray will be used to analyze PBL RNA 
from wild dolphins to determine the utility of "transcriptional signatures" in revealing 
dolphin health status. 
This work was supported by awards from the Office ofNaval Research (#N00014-02-1-
0386) and from NOAA (contract #WC133C04CN0012). Studies on wild dolphins were 
conducted under Scientific Research Permit# 998-1678-00 from the National Marine 
Fisheries Service. 
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Establishment and Characterization of Epidermal Cell Cultures (Ds I) from the Skin of 
the Atlantic Bottlenose Dolphin (Tursiops truncatus) 
Jin, Yu1, M.S. Kindy1'2'6, J. E. Baatz2•3, M. Peden-Adams2•3, T. J. Ellingham4, D. J. 
Wolff, P. A. Fair2•7, and S. Gattoni-Celli2•5•6 
1Department of Neuroscience, Medical University of South Carolina, Charleston, SC; 
2Marine Biomedicine and Environmental Sciences Center, Charleston, SC; 3Department 
of Pediatrics, Medical University of South Carolina, Charleston, SC; 4Department of 
Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, 
SC; 5Department of Radiation Oncology, Medical University of South Carolina, 
Charleston, SC 
6Ralph H. Johnson VA Medical Center, Charleston, SC 
The Atlantic bottlenose dolphin (Tursiops truncatus), a marine mammal found off the 
Atlantic coast, has become the focus of considerable attention. Assessment of the 
impacts of environmental stressors on bottlenose dolphins (BND) has been difficult 
because of the protected status of these marine mammals. Because of the prevalence of 
skin pathologies in BND at the Indian River Lagoon (Florida), the studies presented 
herein focused on establishing epidermal cell cultures as a tool for future evaluation of 
environmental stressors on BND skin in vitro. Primary epidermal cell cultures (DSI) 
were established from skin samples obtained from Atlantic bottlenose dolphins. The in 
vitro epidermal cell cultures were subjected to karyotype analysis and further 
characterized using immunohistochemical methods demonstrating that DS I cultures 
express cytokeratins. Further comparisons using 2-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE) demonstrated that the proteomic profile ofBND skin tissue 
samples was similar to that of skin-derived DS 1 cultures. Epidermal cell cultures derived 
from Tursiops truncatus will provide a unique tool for studying key features of the 
interaction occurring between dolphins and the environment in which they live at their 
most crucial interphase: the skin. 
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Prevalence of Zoonotic Protozoa Infecting Bottlenose Dolphins 
Ron Fayer1, M. Santin\ J.P. Dubey1, P. A. Fair2, G. D. Bossart3, C. Sreekumar1, 0. C. H. 
Kwok1, and P. H. Thulliez4 
1United States Department of Agriculture, Beltsville, MD, 2National Oceanic and 
Atmospheric Administration/National Ocean Service, Charleston, SC, 3Harbor Branch 
Oceanographic Institute, Fort Pierce, FL, 4Institut de Puericulture, Paris, France 
Although Giardia and Cryptosporidium have been detected in a small number of seals 
and sea lions, neither they nor any species of Micro sporidia have been detected in 
dolphins. Fecal specimens obtained in 2004 from 32 bottlenose dolphins in the Indian 
River Lagoon, FL and from 29 dolphins from the Charleston, SC collection areas were 
cleaned of debris by sieving. A 2 J.Ll suspension from each specimen was spotted onto a 
glass microscope slide, stained with fluorescein-labeled antibody to Giardia and 
Cryptosporidium, and examined by fluorescence microscopy. DNA was extracted from 
the remainder of each specimen and polymerase chain reaction (PCR) was applied using 
generic primers for the 18S ribosomal RNA genes of Giardia, Cryptosporidium, and 
Microsporidia. Neither microscopy nor PCR detected any of these parasites except for 3 
dolphins from which DNA for fish Microsporidia were detected. 
Toxoplasma gondii has not been isolated from dolphin tissues. In the present study, sera 
from 146 (60 from 2003, and 86 from 2004) dolphins from the IRL and Charleston sites 
were tested for antibodies to T. gondii. Sera from 2003 were tested by the direct 
agglutination test (DAT), modified agglutination test (MAT), indirect fluorescent 
antibody test (!FAT), the Sabin-Feldman dye test (DT), and an indirect hemagglutination 
test (!HAT). For sera from 2003, 60 dolphins were seropositive with MAT titers of 1:20 
in 3, 1:40 in 19, 1:80 in29, 1:160 in 2, 1:1,280 in 3, 1:2,560 in 2, and 1:5,120 or higher in 
2 and these results were confirmed by DA T results. Dye test titers for these dolphins were 
< 1:10 in 53, 1:800 in 3, 1:1,600 in 2, and 1:3,200 in 2. IHAT titers were< 1:64 in 52, 
1:128 in 1, 1:512 in 2, and 1:2,048 in 5. The IFAT titers were< 1:20 in 3, 1:20 in 47, 
1:80 in 9. For sera from 2004, MAT antibodies were found in 86 of 86 dolphins with 
titers of 1:25 in 29, 1:50 in 23, 1:100 in 27, 1:200 in 3, 1:1,600 in 1, and 1:3,200 in 3; 
these sera were not tested by other tests. In summary, MAT antibodies were found in 
100% of the 146 dolphin sera tested. 
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Detection of Erysipelothrix rhusiopathiae Antibodies in Tursiops truncatus 
Rhonda A. Patterson 
University of Southern Mississippi, Hattiesburg, MS 
Erysipelothrix rhusiopathiae is a Gram positive bacilli which is pathogenic to a variety of 
mammals, birds and some aquatic animals. The consumption of contaminated fish is one 
possible cause of E. rhusiopathiae infection in captive marine mammals, and since acute 
erysipelas in a cetacean can lead to death before any symptoms are seen, erysipelas can 
be considered one of the most problematic diseases seen at aquatic parks housing captive 
cetaceans. A diagnostic assay which could be applied routinely to monitor antibody titers 
against this pathogen would be useful in monitoring ongoing immune status. The 
specificity and amplification of results using an enzyme linked immunosorbent assay 
(ELISA), as well as less complex protocols compared to equally sensitive assays 
(radioimmunoassays) are proof of the need for ELISA assays as the routine assay to 
detect E. rhusiopathiae antibody titers in captive or free ranging cetaceans. The assay 
developed by this laboratory uses a combination of capture antigens extracted from the 
surface of an isolate of E. rhusiopathiae, provide by the U.S. Navy Marine Mammal 
Program from a Tursiops gilli that succumbed to a septicemic case of erysipelas, to coat 
the wells. It also uses antisera specifically developed for Tursiops truncatus to detect 
their antibodies. Serum samples (collected in the summer of 2004) from twenty-two free 
ranging Atlantic bottlenose dolphins (Tursiops truncatus) in the Charleston, South 
Carolina area were assayed. Statistical analysis of the results was performed. Of the 
twenty-two samples assayed, one sample was found to have no titer (or a titer of<l/100, 
the lowest dilution tested); one sample had a titer of 1/100; five samples had titers of 
1/1000; ten samples had titers of 1/10,000; four samples had titers of 1/100,000; and one 
sample had a titer of 1/1,000,000. These results were not unexpected and compare 
favorably with other free ranging dolphin samples that have been assayed as well as 
results seen in captive animals housed in open ocean pens with high human traffic and/or 
closed facilities with sand filtration systems. Further erysipelas analysis will include 
samples for 2004 IRL dolphins in addition to banked 2003 serum samples from animals 
at both sites. 
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Assessment ofMicroflora in Dolphins from the Indian River Lagoon, FL and Charleston, 
sc 
John Pisani1 and P. A. Fair 2 
1Micrim Labs, Fort Lauderdale, FL; 2National Oceanic and Atmospheric Administration, 
National Ocean Service, Center for Coastal Environmental Health & Biomolecular 
Research, Charleston, SC 
We report here the results of a study on the bacterial and fungal microorganisms 
recovered from dolphins of the Indian River Lagoon, Florida (IRL) and the Charleston 
Harbor System, Charleston SC. (CHS). Each dolphin's microbiota was assessed by 
culture of the blowhole, gastric contents and feces. All cultures were evaluated by the 
use of six different bacterial media (tryptic soy agar w/ 5% sheep blood, MacConkey, 
Hektoen enteric, thiosulfate citrate bile sucrose agar, Saboroud dextrose agar with 
chloramphenicol and thioglycollate nutrient broth) and for fungal assessment; fungal 
media used were (Saboroud, Saboroud's with Chloramphenicol, Malt extract, and 
Mycobiotic agar) cultured at room and elevated temperatures. Blowhole cultures from 76 
dolphins evaluated in 2003 yielded a total of 22 different bacteria with a predominance of 
Aeromonas hydrophila (19%) followed by Plesiomonas shigelloides (17%), Vibrio 
alginolyticus (11% ), Pseudomonas jluorescens (9%) and Pseudomonas aeruginosa (7% ). 
The greatest incidences of mycotic isolation from blowhole cultures were in the Genus 
Candida, with several true fungi being represented. During 2004, blowhole cultures 
evaluated from 50 dolphins yielded a total of 24 different bacteria with a predominance 
of Aeromonas hydro phi/a (21% ), Pseudomonas jluorescens (20% ), E. coli (7% ), 
Plesiomonas shigellides (7%), Shewanella putrefaciens (7%) and Vibrio alginolyticus 
( 6% ). Gastric cultures had a greater incidence of yeast isolations as well as 13 different 
bacterial isolates, with the greatest representations being Bacillus sp. (11% of isolates) 
· and Clostridiumperfringens (10% of isolates). Finally, 18 different bacteria were 
isolated from fecal cultures, with the greatest incidence being E. coli (32% of isolates) 
and 26% of isolates being Plesiomonas shigelloides. Over a two-year period, bacterial 
isolations from both sites (IRL and CHS) had negligible differences as well as no major 
difference in representations of genders. Microbial data will be subjected to statistical 
analysis and compared with other health parameters such as immune status and disease. 
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Antibiotic Resistant Escherichia coli Found in Wild Dolphin Populations 
1National Oceanic and Atmospheric Administration, National Ocean Service, 
Charleston, SC; 2Division of Marine Mammal Research and Conservation, Harbor 
Branch Oceanographic Institution, Ft. Pierce, FL 
It has been hypothesized that the wide spread use of antibiotics in humans, pets, and 
agriculture may be causing a carryover of antibiotics and antibiotic resistant bacteria into 
the natural environment. This carryover has been supported by documentation of 
antibiotic resistant bacteria in a variety of wild caught species. To investigate these 
finding further, fecal samples collected during a health assessment study of bottlenose 
dolphins (Tursiops truncatus) from the Indian River Lagoon (IRL), Florida and the 
Charleston Harbor area (CH), South Carolina in 2003 were tested for antibiotic resistant 
Escherichia coli. The IRL is a shallow water ecosystem characterized by residential and 
undeveloped areas with limited water exchange; while the CH harbor estuary is 
characterized by residential, urban and light industrial with a high rate of water exchange 
due to the confluence of the Cooper, Ashley and Wando Rivers. E. coli were cultured 
from fecal samples or rectal swabs and evaluated for resistance to 25 antibiotics using a 
modified Behring Microscan RUO panel. Of the 15 animals captured in the IRL, three 
(20%) exhibited antibiotic resistance to one or more of the antibiotics tested. Of the 23 
animals captured in CHS 16 (70%) exhibited resistance to one or more of the antibiotics 
tested. Data from this study on antibiotic resistant E. coli in wild caught dolphins will be 
included in a larger assessment of health and environmental parameters to further our 
understanding on the transfer and potential impacts of antibiotic resistance in coastal 
dolphins. 
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The Dolphin HERA Project: What Can Fatty Acid Profiles Tell Us About Dolphin 
Health? 
Holbrook, M.A. and G. T. Seaborn 
NOAA/National Ocean Service, Marine Forensics Laboratory, Charleston, SC 
Marine mammals use blubber for insulation, buoyancy control, maintaining body shape, 
hydrodynamic streamlining, and energy storage (Koopman 200 I). Blubber tissue is 
composed primarily of fibrous proteins and adipocytes, which are specialized cells that 
store fat as triacylglycerols. Blubber is extremely important metabolically, as most 
marine mammals have very few internal adipose depots (Pond 1998). Lipid profiles of 
blubber may vary among different species, different populations within a single species, 
and age groups within populations. The prevailing assumption is that observed 
differences are largely dependent on individual differences in diet due to preference 
and/or availability, and may also be affected by variation in age, reproductive status, 
health status, temperature, and other metabolic and environmental factors (Bowen 1999). 
In the bottlenose dolphin (Tursiops truncatus), the fatty acid composition of blubber 
triacylglycerols changes seasonally and has been shown to change differentially among 
stratified layers in blubber depth. It has been suggested that the inner blubber layer is 
more metabolically active, reflecting seasonal changes, while the outer blubber is more 
representative of historical feeding habits and may be more useful in population studies 
(Reeks 2004). Fatty acid profiles in inner and outer blubber biopsies from bottlenose 
dolphins captured in the HERA project may thus reflect both short- and long-term 
differences within and among populations and will provide baseline profiles to aid in 
. assessing individual, population, and ecosystem health. 
Blubber biopsies from bottlenose dolphins captured in Charleston, SC (CHS) and Indian 
River Lagoon, FL (IRL) during the summer season in 2003 and 2004 were divided into 
inner and outer blubber by gross morphology. Mean blubber depth of2003 and 2004 
samples were compared by location, indicating no difference between the two years in 
CHS samples, but a significant difference in IRL animals sampled in 2003 and 2004 (p < 
0.0001). This is likely due to sample collection, rather than a physiological change in 
blubber depth in the animals. The need for standardized techniques in field sample 
collection was recognized by both laboratory and field scientists. No significant 
difference was observed between blubber depths measured in the field by ultrasound and 
in the laboratory at the time of analysis in the 2004 samples from both CHS and IRL, 
suggesting that sampling technique improved between 2003 and 2004. 
Blubber lipids were extracted in hexane, transesterified to form fatty acid methyl esters 
(FAME), and analyzed by gas chromatography with flame ionization detection for 
quantitation and mass spectrometric detection used in conjunction with the analysis of 
reference standards for peak identification. Review and verification of chromatographic 
data are in progress. Preliminary results show 144 FAMEs identified in CHS and IRL 
2004 outer blubber samples. Eliminating FAMEs with mean weight percent values less 
than 0.5% resulted in a list of28 FAMEs that accounted for 88.2% of total weight percent 
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on average (range 83.4-90.8%). Multivariate statistical methods for data analysis will be 
used to examine fatty acid profile data in conjunction with other indicators of health. 
Correlations with age, adipocyte cell counts and areas from histological analysis, and 
post-nuchal fat pad depth measured in the field will be explored. 
Literature Cited 
Bowen, W. D., and D. B. Sniff. 1999. Distribution, population biology, and feeding 
ecology of marine mammals. In Biology of Marine Mammals, ed. J. E. Reynolds 
III and S. A. Rommel, 423-484. Washington, DC: Smithsonian Institution Press. 
Koopman, H. N. 2001. The structure and function of the blubber of odontocetes. Ph.D. 
diss., Duke University, Durham, NC. 
Pond, C. M. 1998. The fats of life. Cambridge, UK: Cambridge University Press. 
Reeks, M. R. 2004. An investigation into the use of blubber fatty acid profiles as a means 
to determine dietary history of bottlenose dolphins (Tursiops truncatus) in 
estuarine and nearshore coastal waters around Charleston, South Carolina. MSc. 
diss., The Graduate School of the College of Charleston, Charleston, SC. 
61 
An Exploration Into the Feeding Ecology of Bottlenose Dolphins and Their Potential 
Prey Using Fatty Acids and Stable Isotopes 
Worthy, G. A. J., A.M. Samuel, and T. A.M. Worthy 
Physiological Ecology and Bioenergetics Lab, Department of Biology, University of 
Central Florida, Orlando, FL 
The Indian River Lagoon (IRL) system is a complex of three estuarine lagoons (Mosquito 
Lagoon, Banana River Lagoon, and Indian River Lagoon) that extends approximately 
253 km (155 mi) along Florida's east coast from latitude 29° 05'N to 26° 58'N. This 
system is a relatively closed system with only three inlets to the ocean, and is home to a 
resident population of bottlenose dolphins (Tursiops truncatus) and many resident/limited 
migration fish species. Both dolphins and fish have been extensively studied in terms of 
their preferred prey species and behavior, making the IRL a unique system for examining 
feeding ecology using stable isotopes and fatty acid signatures. Preferred prey species for 
these dolphins have previously been identified through stomach content analyses, and 
represent a wide variety of feeding strategies, from benthic detritivores such as mullet, to 
omnivores and carnivores such as pinfish. The purpose of this on-going study is to 
examine the inter-relationships between fatty acid and isotopic signatures of bottlenose 
dolphins and their presumed prey in the IRL, with the ultimate goal of interpreting 
bottlenose dolphin feeding habits. 
Fish were collected bimonthly in the IRL and were immediately frozen and stored at -
20°C until analyzed. Blubber samples were collected from live dolphins using either 
biopsy darts on free-swimming animals or as part of a live-capture operation. Blubber 
samples were also opportunistically collected from fresh dead-stranded dolphins 
(condition code 2 or early 3) in the IRL. Prey species were individually measured and 
weighed, then ground to homogeneous consistency before being sub-sampled for further 
analyses. Lipids were extracted from each fish sub-sample using a solution of2:1 
chloroform/methanol. Fatty acid methyl esters were prepared from the extract using 
acid-catalyzed methylation. Esters were purified in hexane, then analyzed using gas-
liquid chromatography. Resultant chromatograms were compared to known standard 
mixtures and secondary external reference standards to determine fatty acid composition. 
Sub-samples of each fish sample were hand ground to powder after lipid extraction, and 
aliquots analyzed for stable isotopes of carbon (13C) and nitrogen C5N) using a Delta 
Finnigan Mat isotope ratio mass spectrometer. Isotope ratios were determined as: 
OX= [(RsampiJRstandard)-1] X 1000 
where X is 15N or 13C and R is the corresponding ratio of 15N/14N or 13C/2C 
(%o).Statistical tests included both univariate and multivariate techniques. 
Preliminary results indicated that fatty acid composition of blubber differed significantly 
between sununer and winter seasons. Within each season, samples taken from live 
animals could not be distinguished from dead-stranded animals in terms of their fatty acid 
composition. Differences were noted, however, between samples from live animals that 
were full depth and samples that were shallow depth. As well, gender differences were 
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evident with male and female animals having different fatty acid composition in their 
inner blubber layers. Using fatty acids to distinguish prey items was more difficult with 
some species (e.g., mullet) having distinct signatures, but others (e.g., pigfish) had fatty 
acid signatures similar to other species. Strong seasonal differences in fatty acid 
composition were evident within each prey species. 
Stable isotope signatures were used to further evaluate differences between prey items 
and dolphins. Prey items showed differences in o15N, separating out by trophic level 
( detritivore vs. piscivore ). Some prey items such as pinfish showed drastic changes in 
o15N concentrations, indicating a trophic shift for these fish during the year. There was 
also a difference in o15N concentrations between dolphins sampled in years 1995-1998 
and those sampled in years 2000-2003. By examining prey size between earlier fish 
collections (1991-1992) and more recent collections (2000-2003), a shift is seen in the 
growth curve for many different dolphin prey species. This change in fish size 
corresponding to a change in o15N concentration in dolphin skin could indicate changes in 
prey size and therefore, feeding habits, over the last decade in the IRL. 
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DNA Strand Breaks in Blood of Bottlenose Dolphin from the East Coast of the United 
States 
Richard F. Lee and Karrie Brinkley, Skidaway Institute of Oceanography, 10 Ocean 
Science Circle, Savannah, GA 31411 
The interaction of chemicals with cellular DNA can result in a wide assortment of DNA 
lesions, including a large number of base modifications, strand breaks and cross linkages. 
Exposure to physical agents, such as sunlight and radioactivity, can result in DNA 
damage. Single strand breaks are the most prevalent type of DNA damage in animals 
exposed to genotoxicants. If these different lesions are not repaired there can be altered 
gene expression leading to a number of biological consequences, including effects on 
reproduction and development. Several methods have been used to measure DNA strand 
damage, including micronucleus and sister chromatid exchange assays. A more recent 
assay, which seems to be more sensitive and reproducible than these assays, is the comet 
assay, where DNA strand breaks are determined by measuring the migration of DNA 
from immobilized nuclear DNA. The DNA after electrophoresis is stained with a 
fluorescent DNA-specific dyes. The migration of DNA away from the nucleus is 
quantified in terms of percentage of DNA in the tail or tail moment using image analysis 
software. 
For our studies the comet assay was carried out on dolphin blood. Since marine mammals 
have nonnucleated erythrocytes, DNA strand breaks in lymphocytes are quantified. The 
comet assay on dolphin blood kept at 3°C showed no changes when sampled at 1 ,2,3 and 
4 days of storage. Dolphin blood in cold packs was sent to us by overnight mail and the 
comet assay was carried out within 24 hours of receiving blood sample. To date, the 
blood has been processed for over 200 individual dolphins and the comet assay results are 
being compared with a variety of parameters collected from the dolphins, including 
location of station, chemical analysis of blubber for a number of pesticides and other 
anthropogenic compounds, immune system status and time after blood collection. A 
strong correlation was found between T -cell proliferation and DNA tail moments. Thus, 
increased number of DNA strand breaks correlated with a decreased ability of the T -cells 
to proliferate, i.e. undergo mitosis, which related to the ability of the blood to respond to 
infection. Dolphins with compromised immune system, such as those with viral 
infection, would be expected to show high levels of DNA strand breaks. There seem to 
be some evidence that dolphins when first collected show increased DNA strand breaks 
but several hours after collection most of these dolphins show low levels of DNA strand 
breaks. The large number of blood samples processed suggest that our data set will be 
one of the largest comet assay studies ever conducted on a species other than humans. 
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Uric Acid Levels: Wild and Semi-Domestic Dolphin Populations 
Forrest Townsend1, W. Van Bonn2, S. Wong2, P. A. Fair3, G. D. Bossart4, C. Wabner5, E. 
Jensen2, and T. Smith2 
1BayVet Hospital, Fort Walton, FL; 2U.S. Navy Marine Mammal Program, San Diego, 
CA; 3National Oceanic and Atmospheric Administration, National Ocean Service, 
Charleston, SC; 4Division of Marine Mammal Research and Conservation, Harbor 
Branch Oceanographic Institution, Fort Pierce, FL; 5Mission Pharmacal Labs, San 
Antonio, TX 
Overview. Initial analyses have been conducted on urine samples collected from two wild 
dolphin populations and one semi-domestic population. Aliquots of urine were collected 
into acidified and non-acidified glass tubes and submitted to Mission Pharmacal 
Reference Laboratory (San Antonio, Texas) for determination of multiple physiochemical 
parameter values anticipated to be clinically useful in the evaluation of renal health. 
Statistical Methods. Test results were received from Mission Pharmacal Reference 
Laboratory and analyzed using SAS Release 8.2. Results among wild and Semi-domestic 
populations were compared using a general linear model. Statistical significance was 
defined asap-value< .01. 
Results. The study population included 24 urine samples from 11 semi-domestic dolphins 
and 49 samples from 49 wild dolphins. Wild dolphins had significantly higher levels of 
urine uric acid and uric acid-to-creatinine ratios than semi-domestic dolphins (p-values 
<.0001 and .002, respectively). While animal health variables were not included in this 
initial study, it is interesting to note that two Semi-domestic dolphins receiving hydration 
therapy had the lowest uric acid-to-creatinine ratios compared to the rest of the study 
population. 
Semi-domestic dolphins were more likely to have higher urine sodium than wild dolphins 
(p-value .002). There were no significant differences among wild and semi-domestic 
dolphins when comparing urine pH, ammonia, or potassium. Semi-domestic dolphins did 
not have detectable levels of citrate in the urine. 
Conclusions. There were significant differences in urine uric acid concentration when 
comparing wild and semi-domesticated dolphins. This study does not address potential 
confounders, including fasting status, gender, age, medical treatments, and animal health 
status. Preliminary results indicate, however, that urine uric acid may be a useful tool for 
assessing renal function in dolphins. Future investigations incorporating demographic 
data, complete blood counts, and serum chemistries are needed to help determine the 
importance of urine uric acid in assessing renal health. 
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Graph 1. Box Plots of Urine UA: Creatinine in Wild v. Semi-domestic Dolphin 
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Appendix A. HERA database table relationships and data entry status. 
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~ : 2003-2004 Data Entered/Verified 
~ : 2003 Data Entered/Verified 
~ : 2004 Data Entered/Verified 
~ : 2003 and 2004 Data Unavailable 
>ppendix B. HERA data dictionary. 
Field Name Type 
FB Text 
Date Date 
Report Number Text 
Isolate Text 
Difloxacillin Byte 
Marbofloxacin Byte 
Ampicillin Byte 
Carbencillin Byte 
Clindamycin Byte 
Cephalothin Byte 
Colistin Byte 
Chloramphenicol Byte 
Erythomycin Byte 
Furadantin Byte 
Ceftazidime Byte 
Gentamicin Byte 
Amikacin Byte 
Oxacillin Byte 
Cefotaxime Byte 
Penicillin Byte 
Septra/bactrim Byte 
Tobramycin Byte 
Tetracyclines Byte 
Metronidazole Byte 
Augmentin Byte 
Ciprofloxacin Byte 
Enrofloxacin Byte 
Pipercillin Byte 
Freezebrand. 
Capture date. 
Report number (assigned by lab). 
Isolate tested. 
AntibioticResistance 
Description 
Code representing sensitivity/susceptibility of isolate to difloxacillin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to marbofloxacin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to ampicillin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to carbencillin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to clindamycin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to cephalothin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to colistin (see luABResistance for code descriptions). 
Code representing sensitivity/susceptibility of isolate to chloramphenicol (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to erythomycin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to furadantin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to ceftazidime (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to gentamicin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to amikacin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to oxacillin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to cefotaxime (see JuAB Resistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to penicillin (see luABResistance for code descriptions). 
Code representing sensitivity/susceptibility of isolate to septra/bactrim (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to tobramycin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to tetracyclines (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to metronidazole (see JuAB Resistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to augmentin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to ciprofloxacin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to enrofloxacin (see luABResistance for code 
descriptions). 
Code representing sensitivity/susceptibility of isolate to pipercillin (see luABResistance for code 
descriptions). 
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Field Name 
FB 
Date 
Lab 
Glucose 
Sodium 
Potassium 
Chloride 
Bicarb 
AnionGap 
NA:K 
C02 
BUN 
Great 
BUN/Great 
TProtein 
Albumin 
Globulin 
NG 
DBilirubin 
I Bilirubin 
TBilirubin 
Calcium 
Phosporus 
Magnesium 
UricAcid 
AP 
ALT 
AST 
SOH 
LDH 
CPK 
Amylase 
Lipase 
GGT 
Cholesterol 
Triglyceride 
Iron 
TIBC 
%SAT 
Albumin2 
Alpha1 
Alpha2 
TAipha 
Beta1 
Beta2 
TBeta 
Gamma 
TGiob 
lmmuneTProtein 
lmmuneA/G 
Lipemia 
Hemolysis 
Type 
Text 
Date 
Byte 
Single 
Single 
Single 
Single 
Single 
Single 
Integer 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Freezebrand. 
Capture date. 
Description 
Code representing lab conducting analyses (see luLab for code descriptions). 
Glucose detected in serum from pre-processing blood sample (mg/dl). 
BloodChemistry 
Sodium detected in serum from pre-processing blood sample (mEq/L for Cornell & mmoi/L for Miami). 
Potassium detected in serum from pre-processing blood sample (mEq/L for Cornell & mmoi/L for Miami). 
Chloride detected in serum from pre-processing blood sample (mEq/L for Cornell & mmoi/L for Miami). 
Bicarbonate detected in serum from pre-processing blood sample (mEq/L for Cornell & mmoi/L for Miami). 
Anion gap calculated in serum from pre-processing blood sample (mEq/L for Cornell & mmoi/L for Miami). 
Sodium to potassium in serum from pre-processing blood sample. 
C02 detected in serum from pre-processing blood sample (mmoi/L). 
Blood urea nitrogen detected in serum from pre-processing blood sample (mg/dl). 
Creatinine detected in serum from pre-processing blood sample (mg/dl). 
Ratio of blood urea nitrogen to creatinine in serum from pre-processing blood sample. 
Total protein detected in serum from pre-processing blood sample (g/dl). 
Albumin detected in serum from pre-processing blood sample (g/dl). 
Globulin detected in serum from pre-processing blood sample (g/dl). 
Ratio of albumin to globulin in serum from pre-processing blood sample. 
Direct bilirubin detected in serum from pre-processing blood sample (mg/dl). 
Indirect bilirubin detected in serum from pre-processing blood sample (mg/dl). 
DBilirubin + !Bilirubin (mg/dL). 
Calcium detected in serum from pre-processing blood sample (mg/dl). 
Phosphorus detected in serum from pre-processing blood sample (mg/dl). 
Magnesium detected in serum from pre-processing blood sample (mEq/L for Cornell & mmoi/L for Miami). 
Uric acid detected in serum from pre-processing blood sample (mg/dl; det limit= 0.2). 
Alkaline phosphatase detected in serum from pre-processing blood sample (U/L). 
Alanine aminotransferase detected in serum from pre-processing blood sample (U/L). 
Aspartate aminotransferase detected in serum from pre-processing blood sample (U/L). 
Succinate dehydrogenase detected in serum from pre-processing blood sample (U/L; values reported as"< 2 
U/L" were recorded as 1 U/L). 
Lactic dehydrogenase detected in serum from pre-processing blood sample (U/L). 
Creatine phosphokinase detected in serum from pre-processing blood sample (U/L). 
Amylase detected in serum from pre-processing blood sample (U/L; Cornell values reported as"< 3 U/L" 
recorded as 1.5 U/L and Miami values reported as"< 30 U/L" recorded as 15 U/L). 
Lipase detected in serum from pre-processing blood sample (U/L). 
Gamma-glutamyl transferase detected in serum from pre-processing blood sample (U/L). 
Cholesterol detected in serum from pre-processing blood sample (mg/dl). 
Triglyceride detected in serum from pre-processing blood sample (mg/dl). 
Iron detected in serum from pre-processing blood sample (ug/dl). 
TIBC detected in serum from pre-processing blood sample (mg/dl). 
Percent saturation of 02 in serum from pre-processing blood sample(%). 
Albumin2 detected in serum from pre-processing blood sample (g/dl). 
Alpha1 detected in serum from pre-processing blood sample (g/dl). 
Alpha2 detected in serum from pre-processing blood sample (g/dl). 
Alpha1 + Alpha2 (g/dL). 
Beta1 detected in serum from pre-processing blood sample (g/dl). 
Beta2 detected in serum from pre-processing blood sample (g/dl). 
Total beta detected in serum from pre-processing blood sample (g/dl). 
Gamma detected in serum from pre-processing blood sample (g/dl). 
TAipha + TBela + Gamma (g/dL). 
Albumin2 + TGiob (g/dL). 
Albumin2/TGiob (g/dL). 
Index representing degree of lipemia for blood sample used to derive blood chemistry profile. 
Index representing degree of hemolysis for blood sample used to derive blood chemistry profile. 
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Field Name 
Icterus 
Comments 
Field Name 
FB 
Date 
PNF 
dAntExt 
dAntlnt 
miAntExt 
miAntlnt 
mvAntExt 
mvAntlnt 
miVentExt 
miVentlnt 
mvVentExt 
mvVentlnt 
biopsyExt 
biopsylnt 
Comments 
Field Name 
FB 
Date 
Set 
Tag Type 
NumTags 
TagColor 
Tag Position 
RadioFrequency 
FBLocation 
PreBieed 
PreBieedln 
PreBieedOut 
PostBieed 
PostBieedln 
PostBieedOut 
Morphometries 
Photos 
Physical Exam 
SkinAssessment 
Ultrasound 
CultureBiowhole 
CultureFecal 
CultureGastric 
Urine 
Urine Volume 
Feces 
Tooth 
ToothNum 
Type 
Single 
Text 
Type 
Text 
Date 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Text 
Type 
Text 
Date 
Long Integer 
Text 
Integer 
Text 
Text 
Text 
Text 
Boolean 
Date 
Date 
Boolean 
Date 
Date 
Boolean 
Boolean 
Boolean 
Boolean 
Boolean 
Boolean 
Boolean 
Boolean 
Boolean 
Single 
Boolean 
Boolean 
Integer 
BloodChemistry (continued) 
Description 
Index representing degree of icterus for blood sample used to derive blood chemistry profile. 
Comments. 
BlubberMeasurements 
Freezebrand. 
Capture date. 
Description 
Dorsal post-nuchal fat pad blubber measurement 10 em behind blowhole (em). 
Dorsal external blubber measurement 10 em anterior to dorsal fin (em). 
Dorsal internal blubber measurement 10 em anterior to dorsal fin (em). 
Mid-lateral external blubber measurement 10 em anterior to dorsal fin (em). 
Mid-lateral external blubber measurement 10 em anterior to dorsal fin (em). 
Mid-ventral external blubber measurement 10 em anterior to dorsal fin (em). 
Mid-ventral internal blubber measurement 10 em anterior to dorsal fin (em). 
Mid-lateral external blubber measurement 10 em ventral to dorsal fin (em). 
Mid-lateral internal blubber measurement 10 em ventral to dorsal fin (em). 
Mid-ventral external blubber measurement 10 em ventral to dorsal fin (em). 
Mid-ventral internal blubber measurement 10 em ventral to dorsal fin (em). 
External blubber measurement at biopsy site (em). 
Internal blubber measurement at biopsy site (em). 
Comments. 
Freezebrand. 
Capture date. 
Set number on capture date. 
Description 
Type of tag (roto, roto/radio, satellite, none, etc.). 
Number of tags placed on animal. 
Color of tags. 
Position on dorsal fin that tag was placed. 
Frequency of radio tag. 
Location of freezebrand (rt dorsal, It dorsal, both dorsal, none, both dorsal/body, etc.). 
Indicates if pre-process bleed was performed. 
Needle in time for pre bleed. 
Needle out time for pre bleed. 
Indicates if post-process bleed was performed. 
Needle in time for post bleed. 
Needle out time for post bleed. 
Indicates if morphometries were recorded. 
Indicates if photos were taken. 
Indicates if a physical exam was performed. 
Indicates if a skin assessment was performed. 
Indicates if ultrasound exam was performed. 
Indicates if blowhole culture was obtained. 
Indicates if fecal culture was obtained. 
Indicates if gastric culture was obtained. 
Indicates if urine sample was obtained. 
Volume of urine collected (ml). 
Indicates if a feces sample was obtained. 
Indicates if a tooth was extracted. 
Number corresponding to extracted tooth. 
71 
Captures 
Appendix B. HERA data dictionary (continued). 
Field Name 
NumToxBiopsy 
NumLesBiopsy 
Milk 
Trimester 
FBPerformed 
Radio Telemetry 
Satellite Telemetry 
Comments 
Additional Comments 
Datasheets 
Field Name 
FB 
Date 
Lab 
Dopamine 
Norepinephrine 
Epinephrine 
Field Name 
FB 
Date 
Lab 
Dopamine 
Norepinephrine 
Epinephrine 
Field Name 
FB 
Date 
AvgDnaLow 
CntDnaLow 
AvgDnaNorm 
CntDnaNorm 
Field Name 
FB 
Date 
AvgDnaLow 
Type 
Integer 
Integer 
Boolean 
Byte 
Boolean 
Boolean 
Boolean 
Text 
Description 
Indicates number of blubber biopsies taken. 
Indicates number of biopsies performed on lesions. 
Indicates if milk sample was obtained. 
Indicates trimester of pregnancy. 
Indicates if animal was freezebranded. 
Indicates if radio telemetry was attached. 
Indicates if satellite telemetry was attached. 
Comments. 
Captures (continued) 
Text Additional comments. 
Hyperlink/Memo Link to datasheet. 
Type 
Text 
Date 
Byte 
Single 
Single 
Single 
Type 
Text 
Date 
Byte 
Single 
Single 
Single 
Type 
Text 
Date 
Single 
Integer 
Single 
Integer 
Type 
Text 
Date 
Single 
Freezebrand. 
Capture date. 
Description 
Code representing lab conducting analyses (see luLab for code descriptions). 
CatecholaminesPost 
Dopamine detected in plasma from post-processing blood sample (pg/mL; values reported as "< 20 pg/mL" 
were recorded as 10 pg/mL). 
Norepinephrine detected in plasma from post-processing blood sample (pg/mL). 
Epinephrine detected in plasma from post-processing blood sample (pg/mL). 
Freezebrand. 
Capture date. 
Description 
Code representing lab conducting analyses (see luLab for code descriptions). 
CatecholaminesPre 
Dopamine detected in plasma from pre-processing blood sample (pg/mL; values reported as "< 20 pg/mL" 
were recorded as 10 pg/mL). 
Norepinephrine detected in plasma from pre-processing blood sample (pg/mL). 
Epinephrine detected in plasma from pre-processing blood sample (pg/mL). 
F reezebrand. 
Capture date. 
Description 
CometAssayPost 
Average% DNA detected in tail region using a low pH (approximately 10) treatment on post-processing blood 
sample(%). 
Number of cells used to copmute AvgDnaLow. 
Average% DNA detected in tail region using a normal pH (approximately 14) treatment on post-processing 
blood sample(%). 
Number of cells used to copmute AvgDnaNorm. 
Freezebrand. 
Capture date. 
CometAssayPre 
Description 
Average% DNA detected in tail region using a low pH (approximately 10) treatment on pre-processing blood 
sample(%). 
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Field Name Type 
CntDnaLow Integer 
AvgDnaNorm Single 
CntDnaNorm Integer 
Field Name Type 
FB Text 
Date Date 
superCYP1A1 Single 
midCYP1A1 Single 
deepCYP1A1 Single 
avgCYP1A1 Single 
Comments Text 
Field Name Type 
FB Text 
Date Date 
Source Byte 
Morph Preservation Byte 
Cellularity Byte 
Epithelial Cells Byte 
Inflammation Byte 
PMN Byte 
Lymph Byte 
Mac Byte 
PC Byte 
MC Byte 
Eos Byte 
Bacteria Byte 
Fungus Byte 
Nasitrema Byte 
NonCellularDebris Byte 
pH Single 
Comments Text 
Field Name Type 
FB Text 
Date Date 
Colony Byte 
lmipenem Byte 
Meropenem Byte 
Chlortetracycline Byte 
Oxytetracycline Byte 
CometAssayPre (continued) 
Description 
Number of cells used to copmute AvgDnaLow. 
Average% DNA detected in tail region using a normal pH (approximately 14) treatment on pre-processing 
blood sample(%). 
Number of cells used to copmute AvgDnaNorm. 
Freezebrand. 
Capture date. 
Description 
Superficial blubber layer immunohistochemical (IHC) staining score for cytochrome P4501A 1. 
Middle blubber layer immunohistochemical (IHC) staining score for cytochrome P4501A 1. 
Deep blubber layer immunohistochemical (IHC) staining score for cytochrome P4501A 1. 
Average immunohistochemical (IHC) staining score for cytochrome P4501A 1. 
Comments. 
CYP1A1 
Cytology 
Freezebrand. 
Capture date. 
Description 
Code representing cytology source (see luSource for code descriptions). 
Code representing assessment of morphologic preservation (see luCytology for code descriptions). 
Code representing assessment of cellularity (see luCytology for code descriptions). 
Code representing assessment of epithelial cells (see luCytology for code descriptions). 
Code representing assessment of inflammmation (see luCytology for code descriptions). 
Code representing assessment of PMN (see luCytology for code descriptions). 
Code representing assessment of lymph (see luCytology for code descriptions). 
Code representing assessment of MAC (see luCytology for code descriptions). 
Code representing assessment of PC (see luCytology for code descriptions). 
Code representing assessment of MC (see luCytology for code descriptions). 
Code representing assessment of Eos (see luCytology for code descriptions). 
Code representing assessment of bacteria (see luCytology for code descriptions). 
Code representing assessment of fungus (see luCytology for code descriptions). 
Code representing assessment of nasitremia (see luCytology for code descriptions). 
Code representing assessment of non-cellular debris (see luCytology for code descriptions). 
Fluid pH (gastric cytology only). 
Comments. 
Freezebrand. 
Capture date. 
Description 
Ecoli colony from which antibiotic resistance was tested. 
ecoliAntibioticResistance 
Code representing imipenem concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR1 for 
code descriptions). 
Code representing meropenem concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR1 for 
code descriptions). 
Code representing chlortetracycline concentration (ug/ml) at which ecoli growth was inhibited (see 
luEcoliABR3 for code descriptions). 
Code representing oxytetracycline concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR3 
for code descriptions). 
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Field Name Type 
Tetracycline Byte 
Gentamicin Byte 
Cefoxitin Byte 
Penicillin Byte 
Moxifloxacin Byte 
Ofloxacin Byte 
Chloramphenicol Byte 
NalidixicAcid Byte 
Amikacin Byte 
Nitrofurantoin Byte 
Ceftriaxone Byte 
Amoxicillin Byte 
Ciprofloxacin Byte 
Sulfathiazole Byte 
Cephalothin Byte 
Ampicillin Byte 
Trimethoprim Byte 
TrimSulf Byte 
Azithromycin Byte 
Apramycin Byte 
Erythromycin Byte 
Streptomycin Byte 
Field Name Type 
FB Text 
Date Date 
Lab Byte 
Cortisol Single 
ACTH Single 
ecoliAntibioticResistance (continued) 
Description 
Code representing tetracycline concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR3 for 
code descriptions). 
Code representing gentamicin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR1 for 
code descriptions). 
Code representing cefoxitin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR6 for 
code descriptions). 
Code representing penicillin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR4 for 
code descriptions). 
Code representing moxifloxacin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR2 
for code descriptions). 
Code representing ofloxacin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR2 for 
code descriptions). 
Code representing chloramphenicol concentration (ug/ml) at which ecoli growth was inhibited (see 
luEcoliABR6 for code descriptions). 
Code representing nalidixic Acid concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR3 
for code descriptions). 
Code representing amikacin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR4 for 
code descriptions). 
Code representing nitrofurantoin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR7 
for code descriptions). 
Code representing ceftriaxone concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR4 for 
code descriptions). 
Code representing amoxicillin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR3 for 
code descriptions). 
Code representing ciprofloxacin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR5for 
code descriptions). 
Code representing sulfathiazole concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR9 
for code descriptions). 
Code representing cephalothin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR3 for 
code descriptions). 
Code representing ampicillin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR3 for 
code descriptions). 
Code representing trimethoprim concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR8 
for code descriptions). 
Code representing trimethoprim/sulfamethoxazole concentration (ug/ml) at which ecoli growth was inhibited 
(see luEcoliABR1 0 for code descriptions). 
Code representing azithromycin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR5 
for code descriptions). 
Code representing apramycin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR6 for 
code descriptions). 
Code representing erythromycin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR3 
for code descriptions). 
Code representing streptomycin concentration (ug/ml) at which ecoli growth was inhibited (see luEcoliABR7 
for code descriptions). 
Freezebrand. 
Capture date. 
Description 
Code representing lab conducting analyses (see lul ab for code descriptions). 
Cortisol detected in plasma/serum from post-processing blood sample (ug/dl). 
EndocrinologyPost 
ACTH detected in plasma/serum from post-processing blood sample (pg/ml; values reported as "> 1250 
pg/ml" were recorded as 1250 pg/ml ). 
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Field Name 
FB 
Date 
Lab 
Aldosterone 
Cortisol 
ACTH 
Estradiol 
Progesterone 
Testosterone 
FreeT4 
TotaiT4 
TotaiT3 
Field Name 
FB 
Date 
Start Time 
EndTime 
Results 
Comments 
Field Name 
FB 
Date 
pH 
Comments 
Field Name 
FB 
Date 
Lab 
Wbc 
Rbc 
Hb 
Pcv 
Hct 
Mev 
Mch 
Mchc 
Rdw 
Segs 
Bands 
Lymphs 
Monos 
Eosinos 
Type 
Text 
Date 
Byte 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Type 
Text 
Date 
Date 
Date 
Integer 
Text 
Type 
Text 
Date 
Single 
Text 
Type 
Text 
Date 
Byte 
Single 
Single 
Single 
Integer 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
EndocrinologyPre 
Freezebrand. 
Capture date. 
Description 
Code representing lab conducting analyses (see luLab for code descriptions). 
Aldosterone detected in plasma/serum from pre-processing blood sample (pg/mL). 
Cortisol detected in plasma/serum from pre-processing blood sample (ug/dL). 
ACTH detected in plasma from pre-processing blood sample (pg/mL; values reported as "> 1250 pg/mL" were 
recorded as 1250 pg/mL). 
Estradiol detected in serum from pre-processing blood sample (pg/mL). 
Progesterone detected in serum from pre-processing blood sample (ng/mL; values reported as"< 0.05 
ng/mL" were recorded as 0.025 ng/mL). 
Testosterone detected in serum from pre-processing blood sample (ng/mL; values reported as "< 0.05 
ng/mL" were recorded as 0.025 ng/mL). 
Free-T4 detected in plasma/serum from pre-processing blood sample (ng/dL). 
Total T4 detected in plasma/serum from pre-processing blood sample (ug/dL). 
Total T3 detected in plasma/serum from pre-processing blood sample (ng/mL). 
Freezebrand. 
Capture date. 
Description 
Start time for erythrocyte sedimentation rate test. 
End time for erythrocyte sedimentation rate test. 
Erythrocyte sedimentation rate test results. 
Comments. 
ESR 
GastricPH 
Freezebrand. 
Capture date. 
Gastric fluid pH. 
Comments. 
Freezebrand. 
Capture date. 
Description 
Description 
Code representing lab conducting analyses (see luLab for code descriptions). 
White blood cell count in post-processing blood sample (10 X 3). 
Red blood cell count in post-processing blood sample (10 X 6). 
Hemoglobin in post-processing blood sample (GM%). 
Packed cell volume in post-processing blood sample(%). 
Hematocrit in post-processing blood sample(%). 
Mean corpuscular volume in post-processing blood sample (U3). 
Mean corpuscular hemoglobin in post-processing blood sample (UUG). 
Mean corpuscular hemoglobin concentration in post-processing blood sample(%). 
Relative (or red cell) distributive width in post-processing blood sample (%). 
HematologyPost 
Segmented neutrophils in post-processing blood sample(% for U of Miami, count (10 X 3) for Cornell). 
Band neutrophil in post-processing blood sample(% for U of Miami, count (10 X 3) for Cornell). 
Lymphocytes in post-processing blood sample(% for U of Miami, count (10 X 3) for Cornell). 
Monocytes in post-processing blood sample(% for U of Miami, count (10 X 3) for Cornell). 
Eosinophils in post-processing blood sample(% for U of Miami, count (10 X 3) for Cornell). 
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Field Name 
Basos 
SegsRel 
SegsAbs 
Bands Rei 
BandsAbs 
LymphsRel 
LymphsAbs 
Monos Rei 
MonosAbs 
EosinophilsRel 
EosinophilsAbs 
Nrbc 
Platelet 
Mpv 
tpRef 
RbcMorph 
PltAppearance 
WbcMorph 
Parasites 
PlsAppearance 
SchalmFIB 
Field Name 
FB 
Date 
Lab 
Wbc 
Rbc 
Hb 
Pcv 
Hct 
Mev 
Mch 
Me he 
Rdw 
Segs 
Bands 
Lymphs 
Monos 
Eosinos 
Basos 
SegsRel 
SegsAbs 
BandsRel 
BandsAbs 
Lymphs Rei 
LymphsAbs 
Type 
Single 
Single 
Double 
Single 
Double 
Single 
Double 
Single 
Double 
Single 
Double 
Single 
Single 
Single 
Single 
Text 
Byte 
Text 
Byte 
Byte 
Single 
Type 
Text 
Date 
Byte 
Single 
Single 
Single 
Integer 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Double 
Single 
Double 
Single 
Double 
HematologyPost (continued) 
Description 
Basophils in post-processing blood sample(%). 
Segmented neutrophil in post-processing blood sample(%). 
Segmented neutrophil count in post-processing blood sample (10 X 3). 
Band neutrophil in post-processing blood sample(%). 
Band neutrophil count in post-processing blood sample (10 X 3). 
Lymphocytes in post-processing blood sample(%). 
Lymphocyte count in post-processing blood sample (10 X 3). 
Monocytes in post-processing blood sample(%). 
Monocyte count in post-processing blood sample (10 X 3). 
Eosinophils in post-processing blood sample(%). 
Eosinophil count in post-processing blood sample (10 X 3). 
Nucleated red blood cells in post-processing blood sample (/100 WBC). 
Platelets in post-processing blood sample (thou/uL). 
Mean platelet volume in post-processing blood sample (fL). 
Total protein (measured by refractometer) in post-processing blood sample (g/dL). 
Red blood cell morphology of post-processing blood sample. 
Code representing platelet appearance for post-processing blood sample (see luPitAppearance for code 
descriptions). 
White blood cell morphology of post-processing blood sample. 
Code representing parasite presence in post-processing blood sample (see luParasites for code 
descriptions). 
Code representing plasma appearance for post-processing blood sample (see luPisAppearance for code 
descriptions). 
Schalm FIB of post-processing blood sample (mg/dL; values reported as"< 100 mg/dL" were recorded as 
50 mg/dL). 
F reezebrand. 
Capture date. 
Description 
Code representing lab conducting analyses (see luLab for code descriptions). 
White blood cell count in post-processing blood sample (10 X 3). 
Red blood cell count in post-processing blood sample (10 X 6). 
Hemoglobin in post-processing blood sample (GM%). 
Packed cell volume in post-processing blood sample(%). 
Hematocrit in post-processing blood sample(%). 
Mean corpuscular volume in post-processing blood sample (U3). 
Mean corpuscular hemoglobin in post-processing blood sample (UUG). 
Mean corpuscular hemoglobin concentration in post-processing blood sample(%). 
Relative (or red cell) distributive width in post-processing blood sample(%). 
HematologyPre 
Segmented neutrophils in post-processing blood sample (% for U of Miami, count (10 X 3) for Cornell). 
Band neutrophil in post-processing blood sample(% for U of Miami, count (10 X 3) for Cornell). 
Lymphocytes in post-processing blood sample(% for U of Miami, count (10 X 3) for Cornell). 
Monocytes in post-processing blood sample(% for U of Miami, count (1 0 X 3) for Cornell). 
Eosinophils in post-processing blood sample(% for U of Miami, count (10 X 3) for Cornell ). 
Basophils in post-processing blood sample(%). 
Segmented neutrophil in post-processing blood sample(%). 
Segmented neutrophil count in post-processing blood sample (10 X 3). 
Band neutrophil in post-processing blood sample(%). 
Band neutrophil count in post-processing blood sample (10 X 3). 
Lymphocytes in post-processing blood sample(%). 
Lymphocyte count in post-processing blood sample (10 X 3). 
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Field Name 
Monos Rei 
MonosAbs 
EosinophilsRel 
EosinophilsAbs 
Nrbc 
Platelet 
Mpv 
tpRef 
RbcMorph 
PltAppearance 
WbcMorph 
Parasites 
PlsAppearance 
SchalmFIB 
Field Name 
FB 
Date 
TCeiiPro1 
TCeiiPro2 
TCeiiPro3 
BCeiiPro1 
BCeiiPro2 
NKiysis1 
NKiysis2 
NKiysis3 
NKiysis4 
Lysozyme 
rBurst1 
rBurst2 
Comments1 
MHCII+ 
C02 
CD21 
CD19 
CD4 
Granulocytes 
Monocytes 
Comments3 
Type 
Single 
Double 
Single 
Double 
Single 
Single 
Single 
Single 
Text 
Byte 
Text 
Byte 
Byte 
Single 
Type 
Text 
Date 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Single 
Single 
Text 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Text 
HematologyPre (continued) 
Description 
Monocytes in post-processing blood sample(%). 
Monocyte count in post-processing blood sample (1 0 X 3). 
Eosinophils in post-processing blood sample(%). 
Eosinophil count in post-processing blood sample (10 X 3). 
Nucleated red blood cells in post-processing blood sample (/100 WBC). 
Platelets in post-processing blood sample (thou/uL). 
Mean platelet volume in post-processing blood sample (fL). 
Total protein (measured by refractometer) in post-processing blood sample (g/dL). 
Red blood cell morphology of post-processing blood sample. 
Code representing platelet appearance for post-processing blood sample (see luPitAppearance for code 
descriptions). 
White blood cell morphology of post-processing blood sample. 
Code representing parasite presence in post-processing blood sample (see luParasites for code 
descriptions). 
Code representing plasma appearance for post-processing blood sample (see luPisAppearance for code 
descriptions). 
Schalm FIB of post-processing blood sample (mg/dL; values reported as "< 100 mg/dL" were recorded as 50 
mg/dL). 
Freezebrand. 
Capture date. 
Description 
lmmunologyPost 
Ratio of stimulated (suboptimum concentration of concanavalin A; 1.25 ug/mL culture) to unstimulated T-cell 
proliferation from post-processing blood sample. 
Ratio of stimulated (optimum concentration of concanavalin A; 2.5 ug/mL culture) to unstimulated T-cell 
proliferation from post-processing blood sample. 
Ratio of stimulated (superoptimum concentration of concanavalin A; 5 ug/mL culture) to unstimulated T-cell 
proliferatio from post-processing blood sample. 
Ratio of stimulated (suboptimum concentration of lipopolysacchardie; 60 ug/mL culture) to unstimulated B-
cell proliferation from post-processing blood sample. 
Ratio of stimulated (optimum concentration of lipopolysacchardie; 120 ug/mL culture) to unstimulated B-cell 
proliferation from post-processing blood sample. 
Natural KillerCell lysis expressed as concentration difference of effector to target cells in dilution of 1 
effector:100 leukocyte cells from post-processing blood sample. 
Natural KillerCell lysis expressed as concentration difference of effector to target cells in dilution of 1 
effector:50 leukocyte cells from post-processing blood sample. 
Natural KillerCell lysis expressed as concentration difference of effector to target cells in dilution of 1 
effector:25 leukocyte cells from post-processing blood sample. 
Natural KillerCell lysis expressed as concentration difference of effector to target cells in dilution of 1 
effector:1 2.51eukocyte cells from post-processing blood sample. 
Concentration of lysozyme (read at 5 min) in serum from post-processing blood sample (ug/ul). 
Measurement of superoxide production in serum from post-processing blood sample using calcium ionophore 
as a stimulant (SI). 
Measurement of superoxide production in serum from post-processing blood sample using phorboldibutyrate 
as a stimulant (SI). 
Comments pertaining to TCell, BCell, NKiysis, Lysozome,and rBurst analyses. 
Number of cells positive for MHCII+ surface proteins in serum from post-processing blood sample. 
Number ofT-cells positive for C02 surface proteins in serum from post-processing blood sample. 
Number of B-cells positive for CD21 surface proteins in serum from post-processing blood sample. 
Number of B-cells positive for CD19 surface proteins in serum from post-processing blood sample. 
Number ofT-cells positive for CD4 surface proteins in serum from post-processing blood sample. 
Percent of phagocytosis by all phagocytic cell types in serum from post-processing blood sample. 
Percent of phagocytosis by macrophages in serum from post-processing blood sample. 
Comments pertaining to MHCII+, CD, and phagocytosis analyses. 
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Field Name 
FB 
Date 
TCeiiPro1 
TCeiiPro2 
TCeiiPro3 
BCeiiPro1 
BCeiiPro2 
NKiysis1 
NKiysis2 
NKiysis3 
NKiysis4 
Lysozyme 
rBurst1 
rBurst2 
Comments1 
lgG1 
CRP 
antiMmar 
antiErhu 
antiVchol 
antiEcoli 
antiVpar 
antiVcar 
antiVvul 
Comments2 
MHCII+ 
CD2 
CD21 
CD19 
CD4 
Granulocytes 
Monocytes 
Comments3 
Field Name 
FB 
Age 
AgeDate 
Sex 
Type 
Text 
Date 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Single 
Single 
Text 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Text 
Double 
Double 
Double 
Double 
Double 
Double 
Double 
Text 
Type 
Text 
Single 
Date 
Byte 
Freeze brand. 
Capture date. 
Description 
lmmunologyPre 
Ratio of stimulated (suboptimum concentration of concanavalin A; 1.25 ug/mL culture) to unstimulated T-cell 
proliferation from pre-processing blood sample. 
Ratio of stimulated (optimum concentration of concanavalin A; 2.5 ug/mL culture) to unstimulated T-cell 
proliferation from pre-processing blood sample. 
Ratio of stimulated (superoptimum concentration of concanavalin A; 5 ug/mL culture) to unstimulated T-cell 
proliferatio from pre-processing blood sample. 
Ratio of stimulated (suboptimum concentration of lipopolysacchardie; 60 ug/mL culture) to unstimulated B-
cell proliferation from pre-processing blood sample. 
Ratio of stimulated (optimum concentration of lipopolysacchardie; 120 ug/mL culture) to unstimulated 8-cell 
proliferation from pre-processing blood sample. 
Natural KillerCell lysis expressed as concentration difference of effector to target cells in dilution of 1 
effector:100 leukocyte cells from pre-processing blood sample. 
Natural KillerCell lysis expressed as concentration difference of effector to target cells in dilution of 1 
effector:50 leukocyte cells from pre-processing blood sample. 
Natural KillerCell lysis expressed as concentration difference of effector to target cells in dilution of 1 
effector:25 leukocyte cells from pre-processing blood sample. 
Natural KillerCell lysis expressed as concentration difference of effector to target cells in dilution of 1 
effector:12.5 leukocyte cells from pre-processing blood sample. 
Concentration of lysozyme (read at 5 min) in serum from pre-processing blood sample (ug/uL). 
Measurement of superoxide production in serum from pre-processing blood sample using calcium ionophore 
as a stimulant (SI ). 
Measurement of superoxide production in serum from pre-processing blood sample using phorboldibutyrate 
as a stimulant (SI). 
Comments pertaining to TCell, BCell, NKiysis, Lysozome,and rBurst analyses. 
Concentration of lgG1 antibodies in serum from pre-processing blood sample (mg/mL). 
Concentration of C-reactive protein globulins in serum from pre-processing blood sample (ug/mL). 
Relative antibody activity per 100 ul of Mycobacteria marinum in serum from pre-processing blood sample 
(U/uL). 
Relative antibody activity per 100 ul of Erysipelothrix rhusiopathiae in serum from pre-processing blood 
sample (U/uL). 
Relative antibody activity per 100 ul of Vibrio cholerae in serum from pre-processing blood sample (U/uL). 
Relative antibody activity per 100 ul of Ecoli OH-157 in serum from pre-processing blood sample (U/uL). 
Relative antibody activity per 100 ul of Vibrio parahemolyticus in serum from pre-processing blood sample 
(U/uL). 
Relative antibody activity per 100 ul of Vibrio carchariae in serum from pre-processing blood sample (U/uL). 
Relative antibody activity per 100 ul of Vibrio vulnificus in serum from pre-processing blood sample (U/uL). 
Comments pertaining to lgG1 , CRP, and antibody analyses. 
Number of cells positive for MHCII+ surface proteins in serum from pre-processing blood sample. 
Number ofT-cells positive for CD2 surface proteins in serum from pre-processing blood sample. 
Number of B-cells positive for CD21 surface proteins in serum from pre-processing blood sample. 
Number of 8-cells positive for CD19 surface proteins in serum from pre-processing blood sample. 
Number ofT-cells positive for CD4 surface proteins in serum from pre-processing blood sample. 
Percent of phagocytosis by all phagocytic cell types in serum from pre-processing blood sample. 
Percent of phagocytosis by macrophages in serum from pre-processing blood sample. 
Comments pertaining to MHCII+, CD, and phagocytosis analyses. 
Freezebrand number. 
Age. 
Date on which age was determined. 
Description 
Code representing sex of dolphin (see luSex for code descriptions). 
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I stat Post 
'ield Name TJl(2e Descri(2tion 
'B Text Freezebrand. 
)ate Date Capture date. 
~unTime Date !STAT run time. 
31ucose Single Glucose detected in post-processing blood sample (G/dL). 
3UN Single Blood urea nitrogen detected in post-processing blood sample (mG/dL). 
3odium Single Sodium detected in post-processing blood sample (mmoi/L). 
:>otassium Single Potassium detected in post-processing blood sample (mmoi/L). 
:::hloride Single Chloride detected in post-processing blood sample (mmoi/L). 
:::02 Single C02 detected in post-processing blood sample (mmoi/L). 
~nionGap Single Anion gap ratio of post-processing blood sample (mmoi/L). 
'ict Single Hematocrit of post-processing blood sample (%PCV). 
'ib Single Hemoglobin in post-processing blood sample (g/dL). 
JH Single pH of blood sample taken following exam. 
:>C02 Single Partial pressure, C02 of post-processing blood sample (mmHg). 
'iC03 Single HC03 (bicarbonate) detected in post-processing blood sample (mmoi/L). 
3Eecf Single BEecf (standard bicarbonate) detected in post-processing blood sample (mmoi/L). 
lstatPre 
Field Name TJme Descri(2tion 
FB Text Freezebrand. 
Date Date Capture date. 
RunTime Date !STAT run time. 
Glucose Single Glucose detected in pre-processing blood sample (G/dL). 
BUN Single Blood urea nitrogen detected in pre-processing blood sample (mG/dL). 
Sodium Single Sodium detected in pre-processing blood sample (mmoi/L). 
Potassium Single Potassium detected in pre-processing blood sample (mmoi/L). 
Chloride Single Chloride detected in pre-processing blood sample (mmoi/L). 
C02 Single C02 detected in pre-processing blood sample (mmoi/L). 
AnionGap Single Anion gap ratio of pre-processing blood sample (mmoi/L). 
Hct Single Hematocrit of pre-processing blood sample (%PCV). 
Hb Single Hemoglobin in pre-processing blood sample (g/dL). 
pH Single pH of blood sample taken following exam. 
PC02 Single Partial pressure, C02 of pre-processing blood sample (mmHg). 
HC03 Single HC03 (bicarbonate) detected in pre-processing blood sample (mmoi/L). 
BEecf Single BEecf (standard bicarbonate) detected in pre-processing blood sample (mmoi/L). 
Lipid 
Field Name TJl(2e Descri(2tion 
FB Text Freezebrand. 
Date Date Capture date. 
Lipid Single Average lipid content of PBDE, PCB, and Pesticide samples (%). 
mdiPBDE 
Field Name TJl(2e Descri(2tion 
FB Text Freezebrand. 
Date Date Capture date. 
pbde100 Single Minimum detection limit for pbde100 analysis (ng/g wet weight). 
pbde153 Single Minimum detection limit for pbde153 analysis (ng/g wet weight). 
pbde154 Single Minimum detection limit for pbde154 analysis (ng/g wet weight). 
pbde28 Single Minimum detection limit for pbde28 analysis (ng/g wet weight). 
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Field Name 
pbde47 
pbde99 
Field Name 
FB 
Date 
pcb1 
pcb101 /90 
pcb105 
pcb106/118/123 
pcb107/108 
pcb110 
pcb114 
pcb119 
pcb12 
pcb123 
pcb126 
pcb128/167 
pcb130 
pcb132/153/168 
pcb141 
pcb146 
pcb149 
pcb15 
pcb151 
pcb154 
pcb156 
pcb157 
pcb159 
pcb169 
pcb170/190 
pcb172 
pcb174 
pcb177 
pcb18 
pcb180 
pcb183 
pcb187 
pcb188 
pcb189 
pcb193 
pcb194 
pcb195 
pcb2 
pcb20 
pcb200 
Type 
Single 
Single 
Type 
Text 
Date 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Description 
Minimum detection limit for pbde47 analysis (ng/g wet weight). 
Minimum detection limit for pbde99 analysis (ng/g wet weight). 
F reezebrand. 
Capture date. 
Description 
Minimum detection limit for pcb1 analysis (ng/g wet weight). 
Minimum detection limit for pcb101 /90 analysis (ng/g wet weight). 
Minimum detection limit for pcb105 analysis (ng/g wet weight). 
Minimum detection limit for pcb106/118/123 analysis (ng/g wet weight). 
Minimum detection limit for pcb107/108 analysis (ng/g wet weight). 
Minimum detection limit for pcb11 0 analysis (ng/g wet weight). 
Minimum detection limit for pcb114 analysis (ng/g wet weight). 
Minimum detection limit for pcb119 analysis (ng/g wet weight). 
Minimum detection limit for pcb12 analysis (ng/g wet weight). 
Minimum detection limit for pcb123 analysis (ng/g wet weight). 
Minimum detection limit for pcb126 analysis (ng/g wet weight). 
Minimum detection limit for pcb128/167 analysis (ng/g wet weight). 
Minimum detection limit for pcb1 30 analysis (ng/g wet weight). 
Minimum detection limit for pcb132/153/168 analysis (ng/g wet weight). 
Minimum detection limit for pcb141 analysis (ng/g wet weight). 
Minimum detection limit for pcb146 analysis (ng/g wet weight). 
Minimum detection limit for pcb149 analysis (ng/g wet weight). 
Minimum detection limit for pcb15 analysis (ng/g wet weight). 
Minimum detection limit for pcb151 analysis (ng/g wet weight). 
Minimum detection limit for pcb154 analysis (ng/g wet weight). 
Minimum detection limit for pcb156 analysis (ng/g wet weight). 
Minimum detection limit for pcb157 analysis (ng/g wet weight). 
Minimum detection limit for pcb159 analysis (ng/g wet weight). 
Minimum detection limit for pcb169 analysis (ng/g wet weight). 
Minimum detection limit for pcb170/ 190 analysis (ng/g wet weight). 
Minimum detection limit for pcb172 analysis (ng/g wet weight) .. 
Minimum detection limit for pcb174 analysis (ng/g wet weight). 
Minimum detection limit for pcb177 analysis (ng/g wet weight). 
Minimum detection limit for pcb18 analysis (ng/g wet weight). 
Minimum detection limit for pcb180 analysis (ng/g wet weight). 
Minimum detection limit for pcb183 analysis (ng/g wet weight). 
Minimum detection limit for pcb187 analysis (ng/g wet weight). 
Minimum detection limit for pcb188 analysis (ng/g wet weight). 
Minimum detection limit for pcb189 analysis (ng/g wet weight). 
Minimum detection limit for pcb193 analysis (ng/g wet weight). 
Minimum detection limit for pcb194 analysis (ng/g wet weight). 
Minimum detection limit for pcb195 analysis (ng/g wet weight). 
Minimum detection limit for pcb2 analysis (ng/g wet weight). 
Minimum detection limit for pcb20 analysis (ng/g wet weight). 
Minimum detection limit for pcb200 analysis (ng/g wet weight). 
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mdiPCB 
ppendix B. HERA data dictionary (continued). 
=ield Name 
>cb201 
>cb202 
>cb206 
>cb207 
>cb209 
>cb26 
>cb28/31 
JCb29 
>cb3 
JCb37 
>cb44 
>cb45 
>cb48 
lCb49 
lCb5/8 
lCb50 
lCb52 
lCb56/60 
lCb61/74 
lCb63 
lCb66 
:JCb69 
:Jcb70/76 
:Jcb77 
:Jcb82 
:>cb84 
:>cb87/115 
:>cb88/95 
:>cb89 
:>cb9 
;>cb92 
pcb99 
Field Name 
FB 
Date 
2,4'-DDD 
2,4'-DDE 
2,4'-DDT 
4,4'-DD D 
4,4'-DDE 
4,4'-DDT 
Aldrin 
Beta-HCH 
Cis-chlordane 
Cis-nonachlor 
Dieldrin 
Endosu lfanl 
Endosulfanll 
EndosulfanSulfate 
Gamma-chlordane 
Heptachlorepoxide 
Hexachlorobenzene 
Type 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Type 
Text 
Date 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Description 
Minimum detection limit for pcb201 analysis (ng/g wet weight). 
Minimum detection limit for pcb202 analysis (ng/g wet weight). 
Minimum detection limit for pcb206 analysis (ng/g wet weight). 
Minimum detection limit for pcb207 analysis (ng/g wet weight). 
Minimum detection limit for pcb209 analysis (ng/g wet weight). 
Minimum detection limit for pcb26 analysis (ng/g wet weight). 
Minimum detection limit for pcb28/31 analysis (ng/g wet weight). 
Minimum detection limit for pcb29 analysis (ng/g wet weight). 
Minimum detection limit for pcb3 analysis (ng/g wet weight). 
Minimum detection limit for pcb37 analysis (ng/g wet weight). 
Minimum detection limit for pcb44 analysis (ng/g wet weight). 
Minimum detection limit for pcb45 analysis (ng/g wet weight). 
Minimum detection limit for pcb48 analysis (ng/g wet weight). 
Minimum detection limit for pcb49 analysis (ng/g wet weight). 
Minimum detection limit for pcb5/8 analysis (ng/g wet weight). 
Minimum detection limit for pcb50 analysis (ng/g wet weight). 
Minimum detection limit for pcb52 analysis (ng/g wet weight). 
Minimum detection limit for pcb56/60 analysis (ng/g wet weight). 
Minimum detection limit for pcb61/74 analysis (ng/g wet weight). 
Minimum detection limit for pcb63 analysis (ng/g wet weight). 
Minimum detection limit for pcb66 analysis (ng/g wet weight). 
Minimum detection limit for pcb69 analysis (ng/g wet weight). 
Minimum detection limit for pcb70/76 analysis (ng/g wet weight). 
Minimum detection limit for pcb77 analysis (ng/g wet weight). 
Minimum detection limit for pcb82 analysis (ng/g wet weight). 
Minimum detection limit for pcb84 analysis (ng/g wet weight). 
Minimum detection limit for pcb87/115 analysis (ng/g wet weight). 
Minimum detection limit for pcb88/95 analysis (ng/g wet weight). 
Minimum detection limit for pcb89 analysis (ng/g wet weight). 
Minimum detection limit for pcb9 analysis (ng/g wet weight). 
Minimum detection limit for pcb92 analysis (ng/g wet weight). 
Minimum detection limit for pcb99 analysis (ng/g wet weight). 
F reezebrand. 
Capture date. 
Description 
Minimum detection limit for 2,4'-DDD analysis (ng/g wet weight). 
Minimum detection limit for 2,4'-DDE analysis (ng/g wet weight). 
Minimum detection limit for 2,4'-DDT analysis (ng/g wet weight). 
Minimum detection limit for 4,4'-DDD analysis (ng/g wet weight). 
Minimum detection limit for 4,4'-DDE analysis (ng/g wet weight). 
Minimum detection limit for 4,4'-DDT analysis (ng/g wet weight). 
Minimum detection limit for Aldrin analysis (ng/g wet weight). 
Minimum detection limit for Beta-HCH analysis (ng/g wet weight). 
Minimum detection limit for Cis-chlordane analysis (ng/g wet weight). 
Minimum detection limit for Cis-nonachlor analysis (ng/g wet weight). 
Minimum detection limit for Dieldrin analysis (ng/g wet weight). 
Minimum detection limit for Endosulfanl analysis (ng/g wet weight). 
Minimum detection limit for Endosulfanll analysis (ng/g wet weight). 
Minimum detection limit forEndosulfan Sulfate analysis (ng/g wet weight). 
Minimum detection limit for Gamma-chlordane analysis (ng/g wet weight). 
Minimum detection limit for Heptachlorepoxide analysis (ng/g wet weight). 
Minimum detection limit for Hexachlorobenzene analysis (ng/g wet weight). 
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mdiPesticides 
Appendix B. HERA data dictionary (continued). 
Field Name 
Mirex 
Trans-nonachlor 
Field Name 
FB 
Date 
Lab 
ReportNum 
Date Received 
Date Reported 
Test 
Source 
Growth 
Isolate Type 
Comments 
Field Name 
FB 
Date 
Weight 
Length 
AxillaryGirth 
MaximumGirth 
RostrumToDorsal 
BlowholeToDorsal 
uiToothCount 
urToothCount 
IIToothCount 
lrToothCount 
Fluke Width 
rTesticle 
!Testicle 
Comments 
Field Name 
FB 
Date 
pbde100 
pbde153 
pbde154 
pbde28 
pbde47 
pbde99 
Type 
Single 
Single 
Type 
Text 
Date 
Byte 
Text 
Date 
Date 
Byte 
Byte 
Byte 
Byte 
Text 
Type 
Text 
Date 
Single 
Single 
Single 
Single 
Single 
Single 
Byte 
Byte 
Byte 
Byte 
Single 
Single 
Single 
Text 
Type 
Text 
Date 
Single 
Single 
Single 
Single 
Single 
Single 
mdiPesticides (continued) 
Description 
Minimum detection limit for Mirex analysis (ng/g wet weight). 
Minimum detection limit for Trans-nonachlor analysis (ng/g wet weight). 
Microbiology 
Freeze brand. 
Capture date. 
Description 
Code representing lab conducting analyses (see luLab for code descriptions). 
Report number assigned by lab. 
Date when culture was received. 
Date when results were reported. 
Code representing type of test conducted (see luTes! for code descriptions). 
Code representing source of culture (see luSource for code descriptions). 
Code representing culture growth (see luGrowth for code descriptions). 
Code representing type of isolate (see lulsolateType for code descriptions). 
Comments. 
Morphometries 
Freezebrand. 
Capture date. 
Weight (lb). 
Description 
Straight line measurement, parallel to the body, from the tip of the rostrum to the fluke notch (em). 
Circumferential measurement of the torso immediately caudal to the pectoral fins (em). 
Circumferential measurement of the torso immediately cranial to the origin of the dorsal fin (em). 
Straight line measurement, parallel to the body, from the tip of the rostrum to the distal tip of the dorsal fin 
(em). 
Straight line measurement, parallel to the body, from the center of the blowhole to the distal tip of the dorsal 
fin (em). 
Upper left tooth count. 
Upper right tooth count. 
Lower left tooth count. 
Lower right tooth count. 
Straight line measurement between fluke tips (em). 
Length of right testicle (em). 
Length of left testicle (em). 
Comments. 
Freezebrand. 
Capture date. 
Description 
Non-normalized result of pbde100 analysis (ng/g wet weight; values< MDL reported as MDL/2). 
Non-normalized result of pbde153 analysis (ng/g wet weight; values< MDL reported as MDL/2). 
Non-normalized result of pbde154 analysis (ng/g wet weight; values< MDL reported as MDL/2). 
Non-normalized result of pbde28 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pbde47 analysis (ng/g wet weight; values< MDL reported as MDL/2). 
Non-normalized result of pbde99 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
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:ield Name 
'8 
)ate 
1Cb1 
>Cb101/90 
>Cb105 
>Cb106/118/123 
1Cb107/108 
1Cb110 
1Cb114 
1Cb119 
1Cb12 
1Cb123 
1Cb126 
1Cb128/167 
1Cb13Q 
1Cb132/153/168 
1Cb141 
1Cb146 
1Cb149 
lCb15 
Jcb151 
Jcb154 
JCb156 
Jcb157 
Jcb159 
Jcb169 
Jcb170/190 
Jcb172 
Jcb174 
Jcb177 
Jcb18 
lCb180 
>cb183 
>cb187 
lCb188 
lCb189 
lCb193 
lCb194 
)Cb195 
Jcb2 
>cb20 
>cb200 
>Cb201 
JCb202 
JCb206 
Jcb207 
Jcb209 
Jcb26 
Jcb28/31 
Jcb29 
JCb3 
JCb37 
Jcb44 
Type 
Text 
Date 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Freezebrand. 
Capture date. 
Description 
Non-normalized result of pcb1 analysis (nglg wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb101/90 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb1 05 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb1 06/118/123 analysis (ngfg wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb107/108 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb110 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb114 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb119 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb12 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb123 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb126 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb128/167 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb130 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb132/153/168 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb141 analysis (ng/g w~t weight; values < MDL reported as MDU2). 
Non-normalized result of pcb146 analysis (ngfg wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb149 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb15 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb151 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb154 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb156 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb157 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb159 analysis (ngfg wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb169 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb170/190 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb172 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb174 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb177 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb18 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb180 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb183 analysis (ngfg wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb187 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb188 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb189 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb193 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb194 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb195 analysis (ngfg wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb2 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb20 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb200 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb201 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb202 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb206 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb207 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb209 analysis (ngfg wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb26 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb28/31 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb29 analysis (ng/g wet weight; values< MDL reported as MDU2). 
Non-normalized result of pcb3 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb37 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Non-normalized result of pcb44 analysis (ng/g wet weight; values < MDL reported as MDU2). 
Jcb45 Single Non-normalized result of pcb45 analysis (ng/g wet weight; values < MDL reported as MDU2) . 
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PCB 
Field Name 
pcb48 
pcb49 
pcb5/8 
pcb50 
pcb52 
pcb56/60 
pcb61 /74 
pcb63 
pcb66 
pcb69 
pcb70/76 
pcb77 
pcb82 
pcb84 
pcb87/115 
pcb88/95 
pcb89 
pcb9 
pcb92 
pcb99 
Field Name 
FB 
Date 
2,4'-DDD 
2,4'-DDE 
2,4'-DDT 
4,4'-DDD 
4,4'-DDE 
4,4'-DDT 
Aldrin 
Beta-HCH 
Cis-chlordane 
Cis-nonachlor 
Dieldrin 
Endosulfanl 
Endosulfanll 
EndosulfanSulfate 
Gamma-chlordane 
Heptachlorepoxide 
Hexachlorobenzene 
Mirex 
Trans-nonachlor 
Field Name 
FB 
Date 
PFHxS 
PFOS 
PFOA 
Type 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Type 
Text 
Date 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Single 
Type 
Text 
Date 
Single 
Single 
Single 
PCB (continued) 
Description 
Non-normalized result of pcb48 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb49 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb5/8 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb50 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb52 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb56/60 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb61 /74 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb63 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb66 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb69 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb70/76 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb77 analysis (ng/g wet weight; values< MDL reported as MDL/2). 
Non-normalized result of pcb82 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb84 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb87/115 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb88/95 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb89 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb9 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb92 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of pcb99 analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Pesticides 
Freezebrand. 
Capture date. 
Description 
Non-normalized result of 2,4'-DDD analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of 2,4'-DDE analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of 2,4'-DDT analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of 4,4'-DDD analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of 4,4'-DDE analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of 4,4'-DDT analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Aldrin analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Beta-HCH analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Cis-chlordane analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Cis-nonachlor analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Dieldrin analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Endosulfanl analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Endosulfanll analysis (ng/g wet weight; values< MDL reported as MDL/2). 
Non-normalized result of EndosulfanSulfate analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Gamma-chlordane analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Heptachlorepoxide analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Hexachlorobenzene analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Mirex analysis (ng/g wet weight; values < MDL reported as MDL/2). 
Non-normalized result of Trans-nonachlor analysis (ng/g wet weight; values < MDL reported as MDL/2). 
PFC 
Description 
Freezebrand. 
Capture date. 
Wet weight of perfluorohexane sulfonate (ng/g; 6 C molecule). 
Wet weight of perfluorooctane sulfonate (ng/g; 8 C molecule). 
Wet weight of perfluorooctanoate (ng/g; 8 C molecule). 
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"ield Name 
'FNA 
'FDA 
'FUA 
'FDoA 
'FOSA 
'ield Name 
'B 
>ate 
leterinarian 
\ssessment 
lodyCond 
mFatPad 
)raiCavity 
)raiCavityNotes 
llucMembColor 
.1ucMembCRT 
:yes 
:yes Notes 
~ardio 
~ardioRatePre 
~ardioRatePost 
~ardioRhythm 
~ardioNotes 
~esp 
~espAbnormality 
31ow0dor 
IAucus 
~espNotes 
31Tract 
3utSounds 
3astricFiuid 
=eces 
=ecesNotes 
3enita1Siit 
v'aginaOrPenis 
~ightMammary 
_eftMammary 
~epNotes 
Field Name 
FB 
Date 
jmv1 
jmv1T 
Type 
Single 
Single 
Single 
Single 
Single 
Type 
Text 
Date 
Byte 
Text 
Byte 
Byte 
Byte 
Text 
Text 
Text 
Byte 
Text 
Byte 
Integer 
Integer 
Byte 
Text 
Byte 
Byte 
Byte 
Byte 
Text 
Byte 
Byte 
Byte 
Byte 
Text 
Byte 
Byte 
Byte 
Byte 
Text 
Type 
Text 
Date 
Byte 
Byte 
PFC (continued) 
Description 
Wet weight of perfluorononanoic acid (ng/g; 9 C molecule). 
Wet weight of perfluorodecanoic acid (ng/g; 10 C molecule). 
Wet weight of perfluoroundecanoate (ng/g; 11 C molecule). 
Wet weight of perfluorododecanoate (ng/g; 12 C molecule; values below detection limit of 1 ng/g were 
recorded as 0.5) 
Wet weight of heptadecafluorooctane sulfonamide (ng/g; can be degradated in acids). 
Physical Exam 
Freezebrand. 
Capture date. 
Description 
Code representing attending vet for physical exam (see luVet for code descriptions). 
Subjective assessment of attitude on processing boat (e.g. ocular response, arching, breath holding, jaw 
tone, vocalizations, etc.). 
Code representing body condition index (see luBodyCondition for code descriptions). 
Code representing post-nuchal fat pad index (see luPostNuchal for code descriptions). 
Code representing normalcy of oral cavity (see luNormal for code descriptions). 
Notes pertaining to abnormal oral cavity. 
Color of mucus membrane . 
Color return time of mucus membrane (seconds). 
Code representing normalcy of eyes (see luNormal for code descriptions). 
Notes pertaining to condition of eyes. 
Code representing normalcy of cardiovascular activity (see luNormal for code descriptions). 
Heart rate (/min) pre-respiration. 
Heart rate (/min) post-respiration. 
Code representing rhythm of cardiovascular activity (see luCardioRhythm for code descriptions). 
Notes describing abnormality of cardiovascular activity. 
Code representing normalcy of respiratory activity (see luNormal for code descriptions). 
Code representing respiratory abnormality (see luRespAbnormality for code descriptions). 
Code representing presence of blow odor (see luYesNo for code descriptions). 
Code representing presence/severity of mucus (see luMucus for code descriptions). 
Notes describing abnormality of respiratory system/activity. 
Code representing normalcy of gastrointestinal tract (see luNormal for code descriptions). 
Code representing presence/absence of gut sounds (see luYesNo for code descriptions). 
Code representing normalcy of gastric fluid (see luNormal for code descriptions). 
Code representing normalcy of feces (see luNormal for code descriptions). 
Notes describing abnormality of feces (i.e. texture, color, odor, etc.). 
Code representing normalcy of genital slits (see luNormal for code descriptions). 
Code representing normalcy of vagina or penis (see luNormal for code descriptions). 
Code representing normalcy of right mammary (see luNormal for code descriptions). 
Code representing normalcy of left mammary (see luNormal for code descriptions). 
Notes describing abnormality of reproductive system/organs. 
Freezebrand. 
Capture date. 
Description 
Serology 
Code representing result of dolphin morbillivirus test conducted by Oklahoma lab (see luSerologyResult for 
code descriptions). 
Code representing titer dilution pertaining to dolphin morbillivirus test conducted by Oklahoma lab (see 
luTiterMorbOK for code descriptions). 
85 
Appendix B. HERA data dictionary (continued). 
Field Name Type 
dmv2 Byte 
dmv2T Byte 
pmv Byte 
pmvT Byte 
brucellaRiv Byte 
brucellaRivT Byte 
brucella Card Byte 
lcanicola Byte 
lcanicolaT Byte 
lgrippo Byte 
lgrippoT Long Integer 
lhardjo Byte 
I hard joT Long Integer 
lictero Byte 
licteroT Long Integer 
I pomona Byte 
lpomonaT Long Integer 
I bratislava Byte 
lbratislavaT Long Integer 
vee Byte 
veeT Byte 
eee Byte 
eeeT Byte 
wee Byte 
weeT Byte 
wnile Byte 
wnileT Byte 
toxo1 Byte 
toxo1T Byte 
toxo2 Byte 
toxo2T Byte 
crypto1 Byte 
Serology (continued) 
Description 
Code representing result of dolphin morbillivirus test conducted by Miami lab (see luSerologyResult for code 
descriptions). 
Code representing titer dilution pertaining to result of dolphin morbillivirus test conducted by Miami lab (see 
luTiterMorbMiami for code descriptions). 
Code representing result of phocine morbillivirus test conducted by Oklahoma lab (see luSerologyResult for 
code descriptions). 
Code representing titer dilution pertaining to result of phocine morbillivirus test conducted by Oklahoma lab 
(see luTiterMorbOK for code descriptions). 
Code representing result of brucella abortus RIV test conducted by NVSL (see luSerologyResult for code 
descriptions). 
Code representing titer dilution pertaining to brucella abortus RIV test result (see luTiterBrucNVSL for code 
descriptions). 
Code representing result of brucella abortus card test conducted by NVSL (see luSerologyResult for code 
descriptions). 
Code representing result of leptospira canicola test (see luSerologyResult for code descriptions). 
Code representing titer dilution pertaining to leptospira canicola test result (see luTiterLeptoNVSL for code 
descriptions). 
Code representing result of leptospira grippo test (see luSerologyResult for code descriptions). 
Code representing titer dilution pertaining to leptospira grippe test result (see luTiterLeptoNVSL for code 
descriptions). 
Code representing result of leptospira hardjo test (see luSerologyResult for code descriptions). 
Code representing titer dilution pertaining to leptospira hardjo test result (see luTiterLeptoNVSL for code 
descriptions). 
Code representing result of leptospira ictero test (see luSerologyResult for code descriptions). 
Code representing titer dilution pertaining to leptospira ictero test result (see luTiterLeptoNVSL for code 
descriptions). 
Code representing result of leptospira pomona test (see luSerologyResult for code descriptions). 
Code representing titer dilution pertaining to leptospira pomona test result (see luTiterLeptoNVSL for code 
descriptions). 
Code representing result of leptospira bratislava test (see luSerologyResult for code descriptions). 
Code representing liter dilution pertaining to leptospira bratislava test result (see luTiterLeptoNVSL for code 
descriptions). 
Code representing result of venezuelan equine encephalomyelitis test (see luSerologyResult for code 
descriptions). 
Code representing titer dilution pertaining to venezuelan equine encephalomyelitis test result (see 
luTiterEENVSL for code descriptions). 
Code representing result of eastern equine encephalomyelitis test (see luSerologyResult for code 
descriptions). 
Code representing titer dilution pertaining to eastern equine encephalomyelitis test result (see luTiterEENVSL 
for code descriptions). 
Code representing result of western equine encephalomyelitis test (see luSerologyResult for code 
descriptions). 
Code representing titer dilution pertaining to western equine encephalomyelitis test result (see luTiterEENVSL 
for code descriptions). 
Code representing result of west nile virus test (see luSerologyResult for code descriptions). 
Code representing titer dilution pertaining to west nile test result (see luTiterEENVSL for code descriptions). 
Code representing result of toxoplasma test conducted by USDA lab (see luSerologyResult for code 
descriptions). 
Code representing highest titer dilution pertaining to result of toxoplasma test conducted by USDA lab (see 
luTiterToxoUSDA for code descriptions). 
Code representing result of toxoplasma test conducted by Miami lab (see luSerologyResult for code 
descriptions). 
Code representing titer dilution pertaining to result of toxoplasma test conducted by Miami lab (see 
luTiterToxoMiami for code descriptions). 
Code representing result of cryptosporidium PCR test conducted by USDA lab (see luSerologyResult for 
code descriptions). 
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ield Name Type 
ypto2 Byte 
ypto2T Integer 
1icro Byte 
lasto Byte 
occi Byte 
sperRID Byte 
sperAg Single 
hlam Byte 
hlamT Byte 
:omments Text 
' ield Name Type 
>ate Date 
>et Long Integer 
>urvey Long Integer 
>ighting Byte 
JetOutTime Date 
.atitude Double 
.ongitude Double 
/erbaiLocation Text 
IVaterTemperature Single 
)alinity Single 
IVaterDepthMin Single 
NaterDepthMax Single 
~umEncircled Long Integer 
~umEscapes Long Integer 
~umSetFree Long Integer 
-JumCalves Long Integer 
::omments Text 
=ield Name Type 
=B Text 
)ate Date 
!l.ssessment Byte 
:OpiSioughing Byte 
~akeMarks Byte 
3DLT Byte 
Serology (continued) 
Description 
Code representing result of cryptosporidium test conducted by Miami lab (see luSerologyResult for code 
descriptions). 
Code representing titer dilution pertaining to cryptosporidium test conducted by Miami lab (see 
luTiterCryptoMiami for code descriptions). 
Code representing result of microsporium PCR test conducted by USDA lab (see luSerologyResult for code 
descriptions). 
Code representing result of blasto RID test conducted by Miami lab (see luSerologyResult for code 
descriptions). 
Code representing result of coccidiodes RID test conducted by Miami lab (see luSerologyResult for code 
descriptions). 
Code representing result of aspergillus radial immunodiffusion test conducted by Miami lab (see 
luSerologyResult for code descriptions). 
Aspergillus antigen reported as index of sample reactivity over a negative control (>1.4 considered positive 
in other species). 
Code representing result of chlamydia test conducted by Miami lab (see luSerologyResult for code 
descriptions). 
Code representing titer dilution pertaining to chlamydia result (see luTiterChlamMiami for code descriptions). 
Comments. 
Setlnfo 
Description 
Set date. 
Set number. 
Survey number. 
Sighting number. 
Time net was set. 
Latitude of set location. 
Longitude of set location. 
Verbal description of set location. 
Surface water temperature (C). 
Surface water salinity (ppt). 
Minimum water depth around net compass (ft). 
Maximum water depth around net compass (ft). 
Total number of dolphins encircled. 
Total number of dolphins that escaped. 
Total number of dolphins intentionally set free and not processed. 
Total number of calves encircled. 
Comments. 
SkinAssessment 
Freezebrand. 
Capture date. 
Description 
Code representing general assessment of skin (see luSkinAssessment for code descriptions). 
Code representing characterization of epidermal sloughing (see luEpidermaiSioughing for code descriptions). 
Code representing the prevalence of rake marks (see luRakeMarks for code descriptions). 
Code representing the prevalence of grossly distinct lesion types (see luGDL T for code descriptions). 
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Field Name Type 
FB Text 
Date Date 
LesionNum Byte 
Distribution Byte 
Color Byte 
ColorNotes Text 
Shape Byte 
Shape Notes Text 
Size Byte 
Consistency Byte 
ConsistencyNotes Text 
Status Byte 
CrossDiagnosis Byte 
cdTraumatic Byte 
cd lnfectious Byte 
cdOther Byte 
Biopsy Taken Byte 
HistDiagnosis Byte 
HistNotes Text 
Field Name Type 
FB Text 
Date Date 
SpecificGravity Byte 
pH Byte 
Leukocytes Byte 
Nitrite Byte 
Protein Byte 
Glucose Byte 
Ketone Byte 
Urobilinogen Byte 
Billirubin Byte 
Blood Byte 
Hemoglobin Byte 
Notes Text 
Field Name Type 
FB Text 
Date Date 
Lab Byte 
Creatinine Single 
Cortisol Single 
F reezebrand. 
Capture date. 
Lesion description number. 
Code representing lesion distribution. 
Code representing lesion color. 
Description 
Textual description of colors other than provided options. 
Code representing lesion shape. 
Textual description of shape other than provided options. 
Code representing lesion size. 
Code representing lesion consistency. 
Textual description of consistency other than provided options. 
Code representing lesion status. 
Code representing cross d iagnosis. 
Code representing traumatic cross diagnosis. 
Code representing infectious cross diagnosis. 
Code representing other cross diagnosis. 
Code representing type of biopsy taken. 
Code representing histopathologic diagnosis. 
Textual description of histopathologic diagnosis other than provided options. 
F reezebrand. 
Capture date. 
Description 
Skin lesion 
Urinanalysis 
Code representing specific gravity detected in urine (see luSpecificGravity for code descriptions). 
Code representing pH detected in urine (see lupHurine for code descriptions). 
Code representing amount of leukocytes detected in urine (see luLeukocytes for code descriptions). 
Code representing amount of nitrite detected in urine (see luNitrite for code descriptions). 
Code representing amount of protein (mg/dL) detected in urine (see luProtein for code descriptions). 
Code representing amount of glucose (mg/dL & g/dL %) detected in urine (see luGiucose for code 
descriptions). 
Code representing amount of ketone (mg/dL) detected in urine (see luKetone for code descriptions). 
Code representing amount of urobilinogen (mg/dL) detected in urine (see luUrobilinogen for code 
descriptions). 
Code representing amount of billirubin detected in urine (see luBillirubin for code descriptions). 
Code representing amount of blood (Ery/uL in 2004) detected in urine (see luBiood for code descriptions). 
Code representing amount of hemoglobin (Ery/uL) detected in urine (see luHemoglobin for code 
descriptions). 
Notes. 
Freezebrand. 
Capture date. 
Description 
Code representing lab conducting analyses (see luLab for code descriptions). 
Creatinine in urine sample (mg/dL). 
UrineEndocrinology 
Cortisol to creatinine ratio in urine sample (ug cortisol/g creal; values reported as "< 1.2 ug/g" were recorded 
as 0.6 ug/g). 
88 
ppendix B. HERA data dictionary (continued). 
=ield Name Type 
'8 Text 
)ate Date 
. ab Byte 
\lphaTocopherol Single 
3ammaTocopherol Single 
~etinol Single 
~etinyiPalmitate Single 
/itaminC Single 
Freezebrand. 
Capture date. 
Description 
Code representing lab conducting analyses (see lulab for code descriptions) . 
Alpha tocopherol detected in plasma from pre-processing blood sample (mg/L). 
Vitamins 
Gamma tocopherol detected in plasma from pre-processing blood sample (mg/L; values reported as "none 
detected" were recorded as 0 mg/L). 
Retinol detected in plasma from pre-processing blood sample {mg/L; values reported as"< 0.06 mg/L" were 
recorded as 0.03 mg/L). 
Retinyl palmitate detected in plasma from pre-processing blood sample (mg/L). 
Vitamin C detected in plasma from pre-processing blood sample (mg/L). 
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LookUp Table Code Description LookUp Table Code Description 
luABResistance luCytology 
0 Not Sensitive 0 None 
1 Sensitive 1 Mild/Few 
2 Intermediate Susceptibility 2 Moderate/Moderate Numbers 
3 Moderately Sensitive 3 Severe/Extensive Numbers 
luAiive 
luDetection 
0 Yes 
1 No 0 Negative 
2 Presumed Dead 1 Positive 
2 Borderline 
luBillirubin 
luEcoliABR1 
0 neg 
1 +small 0 S2 
2 ++moderate 1 4 
3 +++large 2 8 
3 16 
luBiood 4 >16 
0 neg/neg 
1 trace/NA luEcoliABR10 
2 + small/about 5-10 0 S2/28 
3 ++ moderate/about 50 1 4/76 
4 +++ large/about 250 2 >4/76 
luEcoliABR2 
luBodyCondition 0 S1 
1 Emaciated 1 2 
2 Underweight 2 4 
3 Ideal 3 8 
4 Overweight 4 >8 
5 Obese 
luEcoliABR3 
luCardioRhythm 0 S4 
0 Regular sinus arrhythmia 1 8 
1 Abnormal arrhythmia 2 16 
3 32 
4 >32 
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_ookUp Table Code Description LookUp Table Code Description 
uEcoliABR4 luGiucose 
0 :;;a 0 neg 
1 16 1 50 
2 32 2 100 (1/10) 
3 64 3 250 (1/4) 
4 >64 4 500 (1/2) 
5 1000 (1) 
uEcoliABR5 6 2000 or more (2+) 
0 :;;1 
1 2 luGrowth 
2 4 0 None 
3 >4 1 Light 
2 Moderate 
uEcoliABR6 3 Heavy 
0 :;;a 
1 16 luHemoglobin 
2 32 0 negative 
3 >32 1 about 10 
2 about 50 
uEcoliABR7 3 about250 
0 :;;16 
1 32 lulsolateType 
2 64 0 Bacterium 
3 12a 1 Fungi 
4 >12a 
luKetone 
uEcoliABRB 0 neg 
0 :;;2 1 5 trace 
1 4 2 15 small 
2 a 3 40 moderate 
3 >a 4 ao large 
5 160 large 
uEcoliABR9 
0 :;;250 lulab 
1 500 0 ARUP 
2 >500 1 Cornell 
2 Miami 
luEpidermaiSioughing 3 Micrim 
0 None 4 NVSL 
1 Generalized 5 USDA 
2 Focal 6 None 
luGDLT 
0 0 
1 :;;2 
2 3-5 
3 >5 
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Appendix C. HERA database lookup table code descriptions (continued). 
LookUp Table Code Description LookUp Table Code Description 
luLeukocytes luPostNuchal 
0 neg 1 Concave 
1 trace 2 Spongy 
2 +small 3 Firm 
3 ++moderate 4 Convex 
4 +++large 
luProtein 
luMucus 0 neg 
0 None 1 trace 
1 Mild 2 + 30 
2 Moderate 3 ++ 100 
3 Severe 4 +++ 300 
5 +++ 500 
luNitrite 6 ++++ 2000 or more 
0 neg 
1 low positive luRakeMarks 
2 high positive 0 0 
1 :52 
luNormal 2 3-5 
0 WNL 3 >5 
1 Abnormal 
luRespAbnormality 
luParasites 0 Rales 
0 None seen 1 Wheezes 
2 Forced blows 
lupHurine 3 Sputtering 
0 5 
1 5.5 luSerologyResult 
2 6 0 Negative 
3 6.5 1 Borderline/Incomplete 
4 7 2 Weak Positive 
5 7.5 3 Positive 
6 8 4 Nonspecific/Contaminated 
7 8.5 5 Not Tested 
6 No Sample/Quantity Not Sufficient; 
luPisAppearance 
0 Normal luSex 
1 Slight hemolysis 0 Female 
2 Moderate hemolysis 1 Male 
3 Marked hemolysis 2 Probable female 
3 Probable male 
luPitAppearance 
0 Adequate 
1 Increase luSkinAssessment 
2 Adequate/clumps 0 Normal 
1 Abnormal 
2 Not Examined 
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ppendix C. HERA database lookup table code descriptions (continued). 
_ookUp Table Code Description LookUp Table Code Description 
uSource luTiterMorbMiami 
0 Blowhole 0 1:10 
1 Fecal 1 1:50 
2 Gastric 
luTiterMorbOK 
uSpecificGravity 0 1:4 
0 1 1 1:6 
1 1.005 2 1:8 
2 1.01 3 1:16 
3 1.015 4 1:32 
4 1.02 5 1:64 
5 1.025 6 1:128 
6 1.03 7 1:256 
luTest luTiterToxoMiami 
0 C/F 0 1:64 
1 C/S 1 1:128 
2 1:256 
luTiterBrucNVSL 3 1:512 
0 1:25 4 1:1024 
1 1:50 5 1:2048 
2 1:100 
3 1:200 luTiterToxoUSDA 
0 1:20 
luTiterChlamMiami 1 1:40 
0 1:5 2 1:80 
1 1:25 3 1:160 
2 1:50 
3 1:100 luUrobilinigen 
0 Normal 
luTiterCryptoMiami 1 0.2 
0 1:4 2 1 
1 1:8 3 2 
4 4 
luTiterEENVSL 5 8 
0 1:10 6 12 
1 1:20 
2 1:40 luVet 
0 Townsend 
luTiterLeptoNVSL 1 Bossart 
0 1:100 2 Varela 
1 1:200 
2 1:400 luYesNo 
3 1:800 0 Yes 
I No 
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